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ABSTRACT 
Atopic dermatitis (AD) is an inflammatory skin disease whose pathogenic 
mechanisms remain unclear. Using a validated human AD-like mouse model, we 
observed that skin remodeling started at a pre-symptomatic stage of AD that 
included cellular infiltration of the hypodermis, accompanied with 
activated/degranulated mast cells (MC). Local MC activation was quantified using 
a novel method of computer-assisted image analysis we developed and reported. 
Using a variation of this method, we defined morphometric parameters allowing 
for quantitation rather than scoring of cellular infiltration. Cell recruitment 
correlated with MC activation, chemokine production and increased levels of 
sphingolipid sphingosine-1-phosphate (S1P), produced by sphingosine kinase-1 
(SphK1). MC or SphK1 deficiency significantly hindered early AD inflammation.  
Chronic AD features skin barrier dysfunction leading to skin lesions due to 
decreased lipid ceramide (CER) content. Interestingly, local CER species C16 
and C24 were significantly increased in pre-symptomatic AD. Accordingly, skin 
CER synthase (CerS, CER synthesis) CerS4, 5 and 6 mRNA mRNA levels were 
statistically augmented. Because of the overall proapoptotic functions of CER, we 
next measured local cleaved/activated caspase 3 levels, the executioner 
caspase in apoptosis. Skin cleaved caspase 3/apoptosis was significantly 
augmented in early AD and correlated with increased endoplasmic reticulum 
(ER) stress-related molecular players. To substantiate the importance of MC in
vi 
 ER stress-induced apoptosis, CER profiling was similarly conducted in treated 
skin samples collected from MC-deficient mice. MC deficiency prevented CER 
increase and local apoptosis that were restored following MC reconstitution.  
Epigenetic regulation of the molecular pathways that drive AD is unknown. 
We identified and validated a microRNA triad 34a-485-486 whose 
downregulation promoted the AD-related pathogenic pathways we have 
unraveled.  
We conclude that MC may initiate AD by driving early skin remodeling and 
cell recruitment through local chemokine and S1P production and CER-elicited 
apoptosis. Moreover, the down-regulation of a miRNA triad de-represses these 
key players of AD pathogenesis. Targeting these pre-symptomatic effector 
mechanisms may offer new prophylactic strategies for AD whose treatment 
remains a clinical challenge.
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FOREWORD 
Mast cells are immune cells of hematopoietic lineage. Differentiation and 
maturation of MC occurs as they reach the vascularized tissues where they will 
reside (Kitamura, 1989). MC exist as two distinct subsets, distinguishable by the 
protease composition of secretory granules. In humans, MCTC contain tryptase, 
chymase, and other proteases, while MCT contain only tryptase (Oskeritzian et 
al., 2005). MCTC (equivalent to connective tissue MC, CTMC) are located in the 
skin, heart, muscle, and submucosa of the small intestines while MCT (equivalent 
to mucosal MC, MMC) are localized to airway epithelia and small intestine 
mucosa (Schwartz, 2005).  
MC, uniquely identified by dual expression of c-kit, stem cell factor (SCF) 
receptor, and high affinity immunoglobulin (Ig) E receptor (FcεRI), are key 
effector cells of IgE-mediated immune responses, including allergic diseases. 
IgE-dependent MC activation occurs following antigen (Ag) cross-linking of 
surface-bound IgE, triggering the release of many mediators. Some mediators, 
such as vasoactive amines (e.g. histamine), neutral proteases (e.g. tryptases and 
chymases), proteoglycans (e.g. heparin) some cytokines and growth factors and 
sphingolipid S1P are pre-stored within MC and released immediately upon 
activation, while prostaglandins, leukotrienes and other pro-inflammatory lipid 
mediators are produced de novo.  In addition, MC can secrete a wide variety of
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growth factors, cytokines, and chemokines in response to various stimuli in a 
tissue and/or species-dependent manner (Galli et al., 2015).  
Human MC and mouse bone marrow-derived MC (BMMC) are important 
tools for analyzing MC responses in vitro. Primary MC can be isolated from 
tissues and expanded ex vivo in the presence of MC-specific growth factors, 
which include SCF (and interleukin (IL)-3 for mouse MC). In addition, MC lines 
are available. The most common MC lines are rat basophilic leukemia (RBL)-2H3 
cells, human HMC-1 and LAD2 cells, derived from patients with MC leukemia 
(Butterfield et al., 1988; Kirshenbaum et al., 2003), and commercially available 
LUVA cells, that spontaneously developed from human blood CD34+ cells 
(Laidlaw et al., 2011). While convenient, cell lines present transformed 
phenotypes with constitutively activated signaling pathways, making primary cells 
preferable for studying MC functions in vitro. 
MC-deficient mice have proven useful for studying the relevance of MC in 
health and disease. Kit, receptor for stem cell factor (SCF, previously called MC 
growth factor), is expressed on all hematopoietic stem cells. While most cells 
gradually lose Kit expression as they mature, MC remain Kit+. Kit W/W-v and Kit W-
sh/W-sh MC-deficient mice feature c-kit mutations. Kit W-sh/W-sh mice present fewer 
abnormalities than Kit W/W-v mice, which are anemic and difficult to breed. In 
addition, Kit W/W-v mice display other phenotypic abnormalities including 
decreased numbers of TCRγδ and spontaneous dermatitis, thus Kit W-sh/W-sh mice 
are preferred (Grimbaldeston et al., 2005). Nonetheless, mutations in Kit may 
alter other cells than MC. To avoid the collateral issues related to c-kit mutations, 
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alternative MC-deficient mice were generated, in which Cre recombinase (Cre) is 
expressed under the control of “MC-restricted” promoters. The mast cell protease 
(Mcpt) 5-Cre; R-DTA mice feature diphtheria toxin alpha (DTA)-induced deletion 
of CTMC only and have an otherwise normal immune system (Dudeck et al., 
2011). Cpa3Cre/+, or “Cre-Master”, mice display a carboxypeptidase A3 (Cpa3)-
directed activation of Cre, which results in eradication of all MC, but also affects 
some T cell populations and basophils (Feyerabend et al., 2011). Cpa3-Cre;Mcl-
1fl/fl, affectionately called “Hello Kitty” mice by Dr. Steve Galli who generated 
them, are similar to the Cpa3Cre/+strain as constitutive reduction in all MC is 
observed with concomitant depletion of basophils (Lilla et al., 2011). Perhaps 
more clinically relevant than MC-deficient models, another approach has been to 
induce MC ablation when desired. To this end, Mcpt5-Cre;iDTR mice (Dudeck et 
al., 2011), “Mas-TRECK mice (Otsuka et al., 2011; Sawaguchi et al., 2012), and 
Cpa3-Cre;iDTR mice (Reber et al., 2014) are all inducible models of MC 
depletion (Galli et al., 2015). To confirm the importance of MC to a specific 
disease state, MC-deficient mice can be conveniently reconstituted through 
adoptive transfer of BMMC from WT or knockout mice of similar C57Bl/6 genetic 
background. 
Sphingosine-1-phosphate (S1P) is a potent sphingolipid metabolite 
important for cell trafficking, proliferation and survival responses. The pleiotropic 
properties of S1P can be attributed to the fact that S1P can bind to 5 specific G 
protein-coupled receptors, termed S1P receptors (S1PR1-5), expressed in 
 4 
various combinations by a variety of different cell types, including T and B cell 
lymphocytes, dendritic cells and mast cells (Spiegel and Milstien, 2011).  
MC can produce S1P both constitutively and upon IgE/Ag activation, 
which concomitantly activates SphK  (Oskeritzian et al., 2008) that phosphorylate 
sphingosine to produce S1P. The two isoforms of SphK have distinct functions in 
MC. SphK2 is most important for production of S1P in the nucleus and other 
subcellular compartments, while SphK1-derived S1P may be transported outside 
of the cell to ligate cell surface S1PR in an autocrine and/or paracrine manner 
(Mitra et al., 2006; Oskeritzian et al., 2008). MC express S1PR1, which plays a 
role in immune cell trafficking and migration, and S1PR2, which stops movement 
mediated by S1PR1 and triggers release of MC granules (Jolly et al., 2004; 
Spiegel and Milstien, 2011).
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CHAPTER 1: INTRODUCTION  
1.1 MAST CELLS AND SPHINGOSINE-1-PHOSPHATE IN EARLY ALLERGIC 
LUNG INFLAMMATION  
We recently demonstrated the importance of MC/S1P signaling, through 
S1PR2, for early T cell recruitment to inflamed lungs in a model of passive 
systemic anaphylaxis (PSA) (Oskeritzian et al., 2015). Mice were passively 
sensitized with IgE anti-2,4-dinitrophenyl (DNP) and later challenged with antigen 
(Ag) DNP-human serum albumin (DNP-HSA). We found that the neutralization of 
extracellular S1P with a specific anti-S1P mAb (SphingomabTM), prior to Ag 
challenge, resulted in significantly decreased levels of circulating histamine, 
monocyte chemoattractant protein 1 (MCP-1)/CCL2), macrophage inflammatory 
protein 1α (MIP-1α)/CCL3 and RANTES/CCL5 compared to an isotype-matched 
negative control Ab. We established that these chemokines were important for 
CD3+ T cell recruitment. Moreover, we identified MC as a local source of CCL2 
and CCL5. Significantly reduced levels of circulating chemokines were detected 
in MC-deficient Kit W-sh/W-sh mice following Ag challenge, compared to WT 
controls. Furthermore, when MC-deficient mice were reconstituted with MC by 
adoptive transfer of BMMC, production of circulating chemokines observed in WT 
mice was restored. Following Ag challenge, Sphingomab recipients and MC-
deficient mice were protected from the drastic drop in core body temperature 
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indicative of anaphylaxis and early pulmonary edema observed in isotype or WT 
controls. These results highlighted MC/S1P axis as a major contributor of tissue 
remodeling during the early phase of allergic responses in the lungs and were 
publicized as the Editor’s Choice of The Journal of Allergy and Clinical 
Immunology and again as a part of the “Advances and highlights in mechanisms 
of allergic disease in 2015” (Wawrzyniak et al., 2016). 
1.2 ATOPIC DERMATITIS 
Atopic dermatitis (AD) is a recurring inflammatory skin disease which 
affects 10-25% of individuals residing in developed countries. Primarily starting in 
early childhood, 85% of patients experience onset of symptoms prior to age 5. 
Individuals affected with AD often develop other allergic disorders, such as 
asthma, food allergies or rhinitis later in life, making it the first manifestation of 
allergies in what has become known as the atopic march. AD occurrence has 
increased in recent years, but is less prevalent in rural areas supporting the 
“hygiene hypothesis” which states that early exposure to infectious agents aids 
immune system development and decreases susceptibility to allergic (and 
autoimmune) disease (Bieber, 2010).  
AD pathogenesis has been attributed to Ag penetration through a 
compromised barrier, which triggers activation of skin resident cells and release 
of many pro-inflammatory mediators, leading to severe itchiness, dry-flaky skin 
and lesions. AD skin displays thickening of the epidermis and dermis layers 
accompanied by accumulation of immune cells (Bieber, 2010; Yoon et al., 2016), 
including effector T cell subsets (Th1, Th2, Th17 and Th22) and MC (Auriemma 
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et al., 2013; Werfel et al., 2016). Molecularly, inflammatory pathways of AD are 
biphasic. The acute phase is thought to be driven by Th2 cells whereas Th1 
immune responses dominate chronic lesions (Bieber, 2010). Observations of 
chronic inflammation associated with AD has prompted many studies, resulting in 
suggested potential targets for therapeutic intervention, including cytokines and 
chemokines present once the disease has developed. Available treatment 
options, for moderate to severe AD, consist in symptom management with 
undesirable side effects such as diabetes, hypertension, gastric ulcers, 
osteoporosis, glaucoma, growth retardation, renal toxicity, liver dysfunction and 
leukopenia (Simon and Bieber, 2014).   
For mild AD, moisturizers can contribute to restoration of the skin barrier. 
Many of these topical skin care products feature addition of the sphingolipid 
ceramide (CER), critical for maintaining barrier functions in healthy individuals. 
AD patients present a loss of very long chain ceramides that compose the 
stratum corneum (SC) layer of epidermis. It has been thought that adding 
ceramides to moisturizer would positively affect SC structure and lipid 
organization. However, a recent study, comparing efficacy of ceramide-rich 
moisturizer on AD patients, found no significant difference in disease severity 
when compared with other moisturizing products (Miller et al., 2011). 
Inflammation results from the coordinated actions of diverse molecular 
pathways driving a variety of altered gene and protein expression. The discovery 
of miRNA, small noncoding molecules that control translation of target mRNA 
and therefore post-transcriptionally fine-tune many biological processes, has 
 8 
prompted new lines of research to better understand AD etiology (Plank et al., 
2013). Sonkoly et al. were the first to conduct a genome-wide analysis of miRNA 
expression in human biopsies of healthy, psoriatic and AD skin samples but were 
ultimately unable to define an AD-specific signature (Sonkoly et al., 2007). In a 
later study, they linked overexpression of miR-155, which targets cytotoxic T 
lymphocyte–associated antigen 4 (CTLA-4), to increased proliferation of TH cells 
in AD (Sonkoly et al., 2010). More recently, Rebane et al. reported that miRNA 
146a is upregulated in keratinocytes from chronic lesions of AD patients, 
contributing to suppression of innate immune responses (Rebane et al., 2014). 
However, there is no study defining the miRNA signature of AD pathogenesis.  
1.3 STATEMENT OF HYPOTHESIS AND AIMS 
Allergenic stimulation releases the multifaceted sphingolipid S1P from 
tissue-resident MC (Mitra et al., 2006; Oskeritzian et al., 2008; Oskeritzian et al., 
2010). Our most recent studies revealed that S1P serves to further propagate 
inflammatory responses through autocrine/paracrine stimulation of MC, creating 
an inflammatory amplification loop, which we have shown is essential to the 
onset of acute pulmonary inflammation As MC are present in normal skin at 
homeostasis and they become more numerous and activated in inflamed skin 
(Bieber, 2010; Liu et al., 2011), we suggest a similar critical role for MC and S1P 
in the onset and progression of skin inflammation. We are proposing to establish 
the contribution of MC in diseased mouse skin samples, compared to healthy 
skins, at the initiation of AD. We anticipate an early-defined MC-driven molecular 
signature at AD onset that may allow for the design of new prophylactic 
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strategies to prevent further disease development. Next, we propose local S1P 
plays a key role in inflammatory cell recruitment through its stimulatory effects on 
MC degranulation, likely propagating inflammation. Moreover, since AD is 
associated with loss of skin barrier functions and because lesional skin of AD 
patients displays decreased ceramide content, we will investigate changes in 
CER levels at early-phase skin inflammation, a time-point which may be more 
receptive to repair strategies. As little is known pertaining to the epigenetic 
regulation of AD by miRNAs, we also propose to investigate miRNA expression 
during AD pathogenesis. 
For this study, we designed the following aims: 
• Aim 1: Establish the molecular mechanisms underlying early skin 
remodeling at the onset of AD  
• Aim 2: Examine how S1P and MC contribute to skin inflammation in early-
phase AD  
• Aim 3: Investigate ceramide species at the initiation of AD  
• Aim 4: Define the regulatory function of miRNA in AD development and 
progression 
To study the direct implication of MC during AD inception, we first developed a 
computer-automated system to measure MC activation status in situ.
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CHAPTER 2: A NEW IMAGE ANALYSIS METHOD BASED ON MORPHOMETRIC 
AND FRACTAL PARAMETERS FOR RAPID EVALUATION OF IN SITU 
MAMMALIAN MAST CELL STATUS1 
2.1 INTRODUCTION 
Mast cells (MC) are long-lived tissue-dwelling cells, found in all 
vascularized tissues at homeostasis, especially at the host/environment 
interfaces, including skin, airways and the gastrointestinal and genitourinary 
tracts (Galli et al., 2011). There is mounting evidence that MC manifest 
substantial immunomodulatory functions in many physiological processes 
through the vast repertoire of mediators they release upon activation (Galli et al., 
2011; Oskeritzian, 2015). Degranulation represents the canonical process 
through which activated MC secrete mediators (Wernersson and Pejler, 2014). It 
refers to rapid exocytosis of granules that occupy about 80% of MC cytoplasm 
and harbor a wide array of preformed bio-active substances (Galli and Tsai, 
2012; Moon et al., 2014). A spectrum of receptor-dependent and independent 
stimuli can activate MC, including physical and mechanical triggers, and the 
                                            
1 Wedman, P., A. Aladhami, M. Beste, M.K. Edwards, A. Chumanevich, J.W. Fuseler, and 
C.A. Oskeritzian. 2015. A New Image Analysis Method Based on Morphometric and 
Fractal Parameters for Rapid Evaluation of In Situ Mammalian Mast Cell Status. Microsc 
Microanal 21:1573-1581.  
 
Reprinted here with permission of publisher. 
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subsequent secretion of histamine, proteases, lipid mediators, cytokines, and 
chemokines (da Silva et al., 2014). To date, investigators are taking advantage of 
MC cytoplasm replete withgranules as intragranular proteoglycans interact with 
metachromatic dyes such as methylene blue (MB) to allow for visualization, 
anatomical distribution and enumeration of MC in tissue sections (Wolters et al., 
2005). The interaction of these highly sulphated structures with dye molecules 
yields a distinct blue/purple color uniquely staining MC cytoplasmic granules 
(Lagunoff, 1974; Wolters et al., 2005). Other commonly used histological 
methods include chloroacetate esterase, but this technique may also stain 
granulocytes (Rafail et al., 2015). Although local MC identiﬁcation may be 
straightforward, microscopic discrimination between intact and degranulated MC 
could be daunting even for trained observers as tissue MC are polymorphic and 
staining intensity may vary even when routinely used. Thus, the universally 
accepted method to substantiate MC activation remains circulating level 
determination of MC-restricted mediators, including tryptase (Schwartz et al., 
1987). However, while unequivocally quantitative, systemic measurements do 
not reﬂect in situ alterations of MC. Because of their strategic location, MC can 
regulate vascular permeability and cell recruitment to initiate local inﬂammation, 
therefore exerting important pathogenic functions (Marshall, 2004). We reasoned 
that image analysis could aid to develop a reproducible, objective and thus 
reliable method to quantify rather than score MC activation. To this end, we 
investigated normal mouse skin samples for MC using the well-established MB 
staining of tissue sections. Images of a large number of MC were captured from 
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four different mice. Next, we considered MC granule-ﬁlled cytoplasm as an object 
and MC as regions of interest (ROI), endowed with size, volume and staining 
intensity parameters. We reasoned that an intact MC should feature higher 
values for these parameters, compared to degranulated MC. Our results 
demonstrate these morphometric parameters precisely classify MC into two 
objective groups, intact and degranulated MC. We further complemented these 
measurements by quantiﬁcation of fractal dimension values for each cellular 
state. Taken together, we have established a rigorous analytical method based 
on acquisition of morphometric data collected from digitized images of tissue 
sections that allows for reliable and objective quantitation of MC activation status. 
Thus, MC disorders may involve aberrant proliferation of MC exempliﬁed by 
mastocytosis, a myeloproliferative neoplasm, but many primary MC diseases 
feature normal MC numbers of abnormal hyperactivity (Hamilton et al., 2011; 
Valent et al., 2011). Chronic MC activation could be challenging to diagnose, 
often accompanied with mild, episodic or atypical symptoms of idiopathic origin 
(Valent et al., 2011). Based on our study, pathological specimens could be 
surveyed for MC status at a greater scale for diagnostic/prognostic purposes in 
MC related disorders or in diseases where MC dysfunction is suspected in the 
absence of pathognomonic signs. 
2.2 MATERIALS AND METHODS 
Reagents  
All chemicals were purchased from Fisher Scientiﬁc (Pittsburgh, PA, 
USA). 
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Animals  
Gender- and aged- matched C57BL/6 mice were purchased from Charles 
River NCI (Frederick, MD, USA). All mice were used at 8–12 weeks of age and 
maintained in a pathogen-free facility. Studies were performed in accordance 
with institutional animal care and use committee guidelines. 
Histology  
For skin tissue collection, mice were euthanized by CO2 asphyxiation. The 
skin from the dorsal back was shaved. Skin samples were collected and ﬁxed in 
10 %-buffered formalin. Fixed tissues were embedded in parafﬁn, sectioned (5 
μm thickness) and mounted on microscope slides. Some slides were stained with 
hematoxylin and eosin. Other slides were de-parafﬁnized in xylene, hydrated 
through graded alcohols, and equilibrated in phosphate-buffered saline. To 
visualize MC, slides were placed in 0.1 % methylene blue (MB) for 5 s, rinsed 
with water, dehydrated in 100 % ethanol and mounted under coverslips with 
cytoseal 60 (Wolters et al., 2005). Sections were imaged with a Nikon E-600 
microscope (Nikon Inc., Melville, NY, USA) equipped with a Micropublisher digital 
camera and images collected with 10× and 40× objectives. Fourteen adjacent 
images were recorded from each section as TIFF ﬁles. Morphometric parameters 
of MC were measured using the MetaMorph® 6.1 Microscopy Automation and 
Image Analysis software (MolecularDevices, Sunnyvale, CA, USA). 
Descriptors of MC Morphology in the Skin  
The morphometric descriptors of area (A), integrated optical density (IOD) 
to generate relative density (IOD/A), and fractal dimension (D) were measured 
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for thresholded and isolated MC residing in the hypodermis and dermis of 
isolated regions of the skin (n = 4 mice). 
Isolation and Area of MC 
In the hypodermis and dermis of digitized images, MC were isolated as 
individual ROI using the hue, saturation, intensity (HSI) color model of the set 
color threshold subroutine of MetaMorph 6.1 software. The area of the cell 
measured excluded holes (non-stained regions) within the ROI. 
IOD of MB-stained MC 
The HSI values were adjusted to isolate the blue/purple metachromatic 
color characteristic of MC as a thresholded region. The cytoplasmic blue/purple 
metachromatic color distinguishes MC from other blue staining in the tissue. 
From the thresholded region, the area (A) of the cell and its IOD were measured 
using the integrated morphometry subroutine of MetaMorph 6.1. The image of 
the individual isolated MC was converted to a gray scale image for further 
analysis of its fractal dimension using the free HarFa imaging software 
(www.fch.vutbr.cz/lectures/imagesci/).  
When using threshold boundaries in an image, the IOD is deﬁned as the 
weighted sum of the image histogram in which each term in the histogram is 
multiplied by the gray value it represents (Walter and Berns, 1981) and is 
expressed by the following equation: 
𝐼𝑂𝐷(𝑇1, 𝑇2) = ∑ H(GV)𝑥 𝐺𝑉𝑇2𝐺𝑉=𝑇1   
where T1 and T2 represent the upper and lower thresholds deﬁning the ROI in 
the histogram, GV the gray value of each pixel, and H(GV) the gray level 
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histogram. Values of IOD were calculated directly from the integrated 
morphometry subroutine of MetaMorph 6.1 software. Using the software’s optical 
calipers, the measurements were reﬁned by setting speciﬁc boundary conditions 
for area and IOD for acceptance of the signal from the individual MC and to 
minimize or eliminate the contributions of any non-speciﬁc and background 
staining. This concept of IOD representing the mass or total amount of stained 
material in an ROI of an image is well-established and has been previously 
applied to diverse topics including the translocation of nuclear factor κB in the 
nucleus (Fuseler et al., 2006; Rogers and Fuseler, 2007), changes in actin 
cytoskeleton in cardiac ﬁbroblasts (Fuseler et al., 2007) and adult stromal stem 
cells (Fuseler and Valarmathi, 2012), and comparison of the architecture of 
normal and tumor microvasculature (Fuseler et al., 2010).  
The IOD measured for the MB-stained MC is a representation of the mass 
and a measurement of the total amount of material in the delineated region. The 
values of the IOD were normalized by being divided by the area (A) of the 
thresholded ROI for the MC. The resulting term of IOD/A allows for comparisons 
to be made between intact MC and MC that have experienced degranulation as 
result of activation. Additionally, IOD/A provides the concept of mass density or 
relative density (Smith et al., 1996) of the intact and degranulated MC. As a mass 
measurement, the values of IOD/A provide further information on the structure 
and distribution of pixels constituting the mass MC granules present within the 
ROI. 
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Fractal Dimension  
MC granular cytoplasm is an irregular and complex object composed of 
proteoglycan-containing granules at different levels of resolution, which are 
functionally and physiologically similar (self-similar). Because of the complexity of 
form, MC cytoplasm cannot be characterized or deﬁned by regular Euclidean 
geometry or dimensions. Regular Euclidean dimension assigns an integer to 
each point or set of points in Euclidean space and includes the familiar 
geometrical descriptors or numbers: 0 to a point,1 to a straight line, 2 to a plane 
surface, and 3 to a volume or three dimensional ﬁgures. These integer 
descriptors are exponents of power functions that describe these objects (Brown 
et al., 2002). Complex macro- or micro-anatomical structures cannot be analyzed 
by regular Euclidean geometry, but can be described quantitatively by fractal 
geometry (Mandelbrot, 1983; Smith et al., 1996). The fractal dimension of 
complex or irregular structures can be described by non-integer numbers, with 
values falling between two-integer topological dimensions. These non-integer 
numbers are described as non-Euclidean and deﬁne the fractal dimension (D) of 
an object. The concept of fractals currently provides a useful method to quantify 
the inherent irregularity or complexity of phenomena (Zhang et al., 2006). In 
general, a fractal is any rough and irregular object consisting of parts that are in 
some way similar to the whole. Because of the self-similar conditions, MC 
cytoplasm can be considered a fractal object and its fractal dimension (D), 
expressed by a non-integer number lying between two Euclidean integer 
topological dimensions (Grizzi et al., 2005). In the case of the two-dimensional 
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images analyzed in this study, the values of D characterizing MC cytoplasm are 
therefore fractional and lie between the Euclidean integers of 1 and 2.  
The box-counting method has been the most widely used and general 
model for applying fractal analysis to biological and non-biological systems and is 
expressed by the formula: 
D = lim
𝑒→0
Log𝑁(𝑒)
Log(
1
𝑒)
 
The box-counting method consists of a grid of boxes of side length size (e) 
superimposed over the image of the structure and N(e) the smallest number of 
boxes of side (e) required to cover the surface or outline of the object completely  
(Dioguardi et al., 2006; Fuseler et al., 2007; Grizzi and Dioguardi, 1999).  Since a 
zero limit cannot be applied to a biological object, here the MC, the fractal 
dimension is determined as the slope of a regression line when Log [N(e)] is 
plotted against Log(1/e) i.e., D = Log [N(e)]/Log(1/e). From the images of 
previously isolated and thresholded MC, the D values of the ROI were 
determined using HarFA (full version 5.5.31) software (Nezadal et al., 2001). The 
thresholded images of MC are assigned mesh sizes of boxes with (e) values 
ranging from 2 to 215 pixels and 30 steps within this range were calculated to 
generate the Log [N(e)] versus Log(1/e) plots, the slopes of which determine the 
D values. In these 40× images, one pixel is equal to 0.229 μm. Fourteen images 
were analyzed from each skin section of each animal (n = 4 mice). 
Statistics  
Data are expressed as means ± SEM. Signiﬁcance was determined by 
analysis of variance and an appropriate post hoc test for multiple comparisons 
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using Sigma-Plot software (Systat Software Inc., San Jose, CA, USA) and is 
shown in ﬁgures.  
2.3 RESULTS 
Methylene Blue Staining of Normal Mouse Skin Sections for MC Detection 
and Analysis  
We used a classic staining technique to visualize MC in skin tissue 
sections. Methylene blue (0.1 % MB) stains all nuclei of cells in blue. Because of 
the metachromatic nature of the proteoglycans that compose the frame of MC 
granules, the interaction of the dye molecules with proteoglycans results in an 
absorption spectrum shift from blue to purple. Thus, metachromasia features 
blue/purple cytoplasmic granules, unique to MC (Wolters et al., 2005). Even 
though the metachromatic cytoplasmic staining is MC-speciﬁc, Figure 2.1a 
shows that in situ MC detection can be challenging, at low magniﬁcation using a 
10× objective of MB-stained skin section. Higher magniﬁcation using a 40× 
objective (or High Power Field, HPF) of similar MC-stained skin tissue sections 
allows for MC identiﬁcation, but illustrates the difﬁculty to decide, even with 
blinded analysis and microscope aided human eyes, whether a particular MC 
presents features of an intact or a degranulated cell (Fig. 2.1b). We developed a 
method for rapid and unequivocal identiﬁcation of MC status, as follows: an intact 
MC was deﬁned as a MC within and/or at the periphery of which no distinct 
granule could be singled out in high power ﬁeld (HPF) (Fig. 2.1b, Intact MC). 
Next, we deﬁned as degranulated, MC for which distinct individual granules could 
be observed within and at the periphery of the cell in HPF (Fig. 2.1b, 
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Degranulated MC). Figure 2.1c describes the analytic ﬂow chart employed to 
quantitatively identify and distinguish between an intact and a degranulated MC. 
To this end, two MC were randomly selected (Fig. 2.1b, Intact MC and 
Degranulated MC), and then isolated as speciﬁc ROI to remove the background 
(Fig. 2.1c, upper panels). Next, isolated MC images were color-thresholded (Fig. 
2.1c, middle panels, orange coloring). The thresholding process was followed by 
the actual determination of pixel intensity (Fig. 2.1c, lower panels, green coloring) 
to measure the IOD parameter which sums the values of all the pixels in the 
selection (cell). We noticed that the area occupied by and the morphology of 
each MC could vary greatly. To take this variable into account, the area (A) 
occupied by each cell was measured next and expressed in square μm. Because 
intact MC granules are fully equipped with a variety of mediators whereas 
degranulated MC have partly released the mediators harbored in their granules, 
we reasoned that intact and degranulated MC must be characterized by 
differential mass or IOD/A measurements, allowing for objective deﬁnition of 
each of these cellular states.  
Relative Mass Calculations Based on IOD/A Ratios Distinctly and 
Quantitatively Characterize Intact and Degranulated MC  
We further analyzed skin tissue sections collected from four different 
animals, and randomly selected 90 intact and 90 degranulated MC, as described 
above. Next, IOD and A parameters were calculated as described in Figure 2.1. 
Quantitation of IOD/A ratios were carried out. As shown in Figure 2.2, intact MC 
exhibit an average IOD/A ratio of 15.459 ± 2.18, which was signiﬁcantly 
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decreased to 11.782 ± 2.109 in degranulated MC. Importantly, these results 
quantitatively substantiate the notion that intact MC feature a higher mass 
compared to degranulated MC. This procedure actually measures relative MC 
mass and demonstrates this parameter to be signiﬁcantly attenuated upon 
degranulation, in agreement with the biological relevance of the process. 
Fractal Dimension Analysis Constitutes a Suitable Analytical Approach to 
Further Deﬁne Morphometric Evaluations of Intact and Degranulated MC  
We next considered that the size and volume parameters previously 
calculated for each MC status could be complemented by quantiﬁcation of 
comparative fractal dimension values. To this end, we sought to determine 
whether fractal dimension, a measure of chaos and space ﬁlling capacity, could 
be a useful discriminating factor between intact and degranulated MC, as there is 
an increasing use of applied fractal geometry in the medical ﬁeld for pattern 
recognition, texture analysis and segmentation. This type of analysis has been 
performed to study cell nuclei and nuclear chromatin and has been demonstrated 
as a useful prognostic tool in cancer  (Ferro et al., 2011; Streba et al., 2015). 
Therefore, we reasoned that the more ordered cytoplasm of an intact MC should 
display contrasted fractal characteristics compared to a more heterogeneous, 
less uniform cytoplasm of a degranulated MC. Figure 2.3a shows the procedure 
to ﬁrst isolate cells to be analyzed from the tissue and second, proceed with 
binarization of the image (i.e., generate a black and white image from a gray-
scale one). Binarized images are next used to calculate fractal dimension (D), 
therefore quantifying the structural density of MC cytoplasm. D values of the two-
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dimensional images analyzed were between the Euclidean values of 1 (a straight 
line) and 2 (an irregular, complex structure). Of note, fractal dimensions 
constitute numerical descriptors which are exponents of power functions, i.e., 
nonlinear functions. 
Fractal Analysis is a Reliable Method for Objective Quantiﬁcation of in situ 
MC Degranulation 
Analysis of normal skin samples collected from four different mice was 
conducted using 14 images per animal and randomly chosen intact MC (n = 29 - 
60 cells per animal) and degranulated MC (n = 14 - 29 cells per animal). The 
fractal dimension of each cell was determined. The discriminatory performance of 
D parameters is shown in Figure 2.4, indicating mean D values of 1.378 ± 0.621 
and 1.484 ± 0.0489 for intact and degranulated MC, respectively. Surprisingly, 
the D values characterizing each MC status were very consistent from animal to 
animal, suggesting the potential relevance of fractal signatures to objectively 
evaluate MC activation status. Moreover, mean D values of degranulated MC 
were signiﬁcantly augmented compared to mean D values of intact MC. We 
established that computer-assisted morphometric MC analysis performed on 
microscopy images of tissue samples may overcome the time-consuming and 
subjective examination that necessitates expertise and extensive observer 
training. 
2.4 DISCUSSION 
Key components of innate immunity, MC are present in tissues apposed to 
the vasculature in homeostatic conditions (Reber et al., 2012). They harbor 
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numerous intracytoplasmic granules, large dense core vesicles composed of a 
proteoglycan matrix where many mediators are pre-stored, including vasodilating 
histamine, cytokines and chemokines (Wernersson and Pejler, 2014). Beside 
their canonical activation through the cross-linking by antigen (Ag) of 
immunoglobulin E (IgE) bound to their high-afﬁnity receptors, MC express a 
plethora of receptors, including Toll-like receptors, and receptors for complement, 
cytokines, chemokines, neurotransmitters and sphingosine-1-phosphate (S1P), 
the ligation of which could also trigger further MC activation (Oskeritzian, 2015; 
Oskeritzian et al., 2008; Oskeritzian et al., 2015; Oskeritzian et al., 2010; 
Theoharides et al., 2012). Moreover, microenvironmental physical/mechanical, 
pH, osmolarity and temperature alterations and UV radiation can also activate 
MC. Degranulation or the exocytosis of granules is the most prominent process 
indicative of MC activation. MC stimulation is traditionally monitored through the 
detection of granule-associated mediators measured in the circulation upon 
release. However, a systemic appreciation of MC activation, though relevant and 
sometimes life-threatening such as upon anaphylactic shock, does not inform on 
the status of local MC in tissues. As outlined above, the distinctive ability of MC 
to produce and pre-store large concentrations of many mediators positions these 
cells as ﬁrst-line responders thus shaping the initial local response to trauma. We 
have previously reported that IgE/Ag- and S1P-mediated activation of MC 
delivers locally several cell-recruiting chemokines, thus endowing MC with early 
guidance of inﬂammatory events (Oskeritzian et al., 2008; Oskeritzian et al., 
2015; Oskeritzian et al., 2010). This is particularly important in skin disorder 
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pathogenesis as the positioning of large numbers of MC is substantiated in the 
dermis and the hypodermis, subcutaneous fatty tissue layer of rodent and human 
skin (Hart et al., 1999; Hart et al., 1998). Strong evidence suggests an 
association between MC-derived functions and the mediator repertoire they 
differentially release owing to the nature of stimulation (Galli et al., 2008; 
Kalesnikoff and Galli, 2008). 
Intragranular proteoglycan interaction with dye molecules of MB results in 
a metachromatic staining of granules speciﬁc to MC, the only tissue-resident 
cells that display these distinct blue/purple-colored granules in their cytoplasm. 
Of note, although circulating basophils share some phenotypic and functional 
features, they differ from MC in many aspects of natural history, granule contents 
and functions (Voehringer, 2013). Relevant to our study, basophils are not found 
in normal tissues (Arock et al., 2002), but could be recruited into inﬂamed sites 
(Voehringer, 2013). Importantly, the main histochemical difference that allows 
distinguishing MC from basophils resides in differential metachromatic staining. 
Namely, MC granules comprise both heparin and chondroitin sulfate (CS) 
proteoglycans, whereas basophil granules present CS but do not contain heparin 
and are fewer in number compared to MC granules, thus resulting into weak 
staining with basic dyes (Voehringer, 2013). Other distinct features of MC are 
their round nuclear morphology and a cell size ranging from 5 to 10 μm, 
conversely to basophils that display lobulated, indented or segmented nuclei and 
an overall smaller size of 5 – 7 μm compared to MC (Voehringer, 2013).  
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While easy to identify in MB-stained tissue sections, deﬁning MC 
activation status remains challenging even for a trained observer and is a source 
of considerable inter-observer variability. Since MC are tissue-resident and could 
initiate or suppress immune responses, they constitute an emerging target 
candidate for ﬁne-tuning the local microenvironmental responsiveness, therefore 
pathogenesis and carcinogenesis (Oskeritzian, 2015). There is increasing need 
for a better understanding pertaining to the relationship of MC in inﬂammation 
and cancer as it seems diversiﬁed and therefore ill-understood (Giannou et al., 
2015; Oldford and Marshall, 2015; Oskeritzian, 2015; Ribatti, 2013). Indeed, 
many studies acknowledge the presence of increased MC numbers in numerous 
pathological conditions, yet reporting the more relevant and tractable local 
percentage or number of degranulated MC is not recognized as strong univariate 
data that often needs to be validated by quantitating MC-derived mediators in 
biological ﬂuids.  
In this study, we developed a computerized method for morphometric 
analysis of MC based on objective parameter measurements in routinely MB-
stained normal skin tissue sections. Of relevance to MC granularity and 
morphology, these criteria include mass and relative density measurements 
based on IOD and area (A) ratios and fractality, which implies scale-independent 
self-similarity. We discovered that, independent of the subject, intact skin MC are 
consistently characterized by a mass (IOD over A ratio) signiﬁcantly higher than 
degranulated MC. Of note, the IOD/A ratios of intact or degranulated MC were 
surprisingly consistent from cell to cell in each group and from animal to animal, 
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further highlighting the reproducibility and validity of our newly developed 
analytical method. Interestingly, the use of IOD and A parameters have 
previously been applied to dermal MC as a tool to quantify histamine content, but 
not to provide a measurement of MC activation as demonstrated herein (Hart et 
al., 1999; Hart et al., 1998). 
The examination of fractal characteristics has been convincingly relevant 
to analyze chromatin structure and nuclear texture, providing important 
diagnostic and prognostic information for patients with acute leukemia and 
multiple myeloma (Ferro et al., 2011). Fractal analysis has been widely applied in 
the past to quantify cytoskeleton morphology  (Fuseler et al., 2007; Fuseler and 
Valarmathi, 2012; Qian et al., 2012), cellular shape (Jelinek et al., 2011; Sedivy 
et al., 2002; Wick et al., 2003), vasculature structure (Anderson et al., 2005; Di 
Ieva et al., 2007; Fuseler et al., 2010; Grizzi et al., 2005), vascular sprouting 
(Doubal et al., 2010; Moledina et al., 2011) and tumor microvasculature (Di Ieva, 
2012; Fuseler et al., 2010). More recently, it was successfully applied to quantify 
collagen ﬁbrotic lesions of the liver (Dioguardi et al., 2008; Dioguardi et al., 2006)  
and the heart (Zouein et al., 2014). Microscopy evaluation of the MC 
degranulation process requires high magniﬁcation analysis and could be difﬁcult 
given staining variations occurring in routine slide preparations. We took 
advantage of the fact that fractals are scale independent and their determination 
based on thresholded images less dependent on staining intensity. Methylene 
blue is one of the most common metachromatic staining methods and well-
established histological approach to detect MC through the unique staining of 
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their granules (Wolters et al., 2005). As such, it could be used to distinguish 
intact from degranulated MC. However, observer-based analysis often yields 
inconsistent data, varying with the individual grading of MC status and provides 
semi-quantitative estimates of MC degranulation rather than reliable quantitation 
partly because of the irregular shapes tissue MC display in situ. Thus, MC 
cytoplasm, 80% of which is occupied by granules, is highly polymorphic and 
irregular in shape. To overcome these conditions, we considered the 
granule/cytoplasm mass as a fractal object, a concept developed by Mandelbrot 
(1982) that provides a theoretical framework for many biological processes and 
objects. Thus, the fractal property relates to a measurement variable and a 
fractal object or process can reveal fractal characteristics of many different 
variables or features. We measured the fractal dimension (D) of intact and 
degranulated MC, as a measure of the comparative space ﬁlling capacity and 
complexity or structural density of MC in these two different biological stages, 
using digitized two-dimensional images. We discovered that D associated with 
intact MC is consistently and signiﬁcantly lower than D of degranulated MC in a 
reproducible manner. These important results suggest that the measure of D can 
quantitatively distinguish intact from degranulated MC, regardless of cellular 
morphology which could greatly vary. Together with the relative density 
measurements provided by the IOD/A ratios, which determines the structure 
and/or distribution of the granular material within a MC (our region of interest), we 
demonstrate that the measure of D generates a quantitative description of 
mammalian MC status. We are currently exploring the feasibility of acquiring 
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these data in a semi-automated manner for potential diagnosis/prognosis 
applications to compare the analysis of healthy and diseased tissue sections in 
MC related disorders. We attributed the detection of some degranulated MC in 
normal skin to the procedure for sample preparation that requires shaving of the 
mouse back skin. This mandatory step constitutes a mild but perhaps signiﬁcant 
mechanical stimulus leading to a low but detectable incidence of dermal MC 
activation.  
Despite the differences between mouse and human skin, mouse models 
of human disease remain prevalent, and in many cases genes of interest are 
deregulated and/or mutated in both species (Gerber et al., 2014). The vast 
abundance of disease models, knockout and transgenic strains ensure that 
mouse models will remain a highly relevant mainstay to the study of skin biology 
(Gerber et al., 2014). Therefore, our morphometric method of MC analysis was 
ﬁrst developed using mouse skin samples. Applying this morphometric method to 
human samples would assist clinicians and hospitals with providing a rapid 
determination of MC activation status, including in suspected cases of MC 
activation syndrome, mastocytosis, and anaphylactoid versus genuine 
anaphylactic reactions (Akin et al., 2010; Hamilton et al., 2011; Valent et al., 
2011). A previous report applied fractal dimension and lacunarity or 
measurement of roughness to characterize MC degranulation in rainbow trout 
(Manera et al., 2014). Although informative, this study did not use mammalian 
MC. Moreover, MC degranulation was triggered in a receptor-independent 
manner using compound 48/80, a synthetic polyamine basic secretagogue 
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composed of mixed polymers of phenylethylamine cross-linked by formaldehyde 
of undetermined ratio thus precluding calculation of molar concentrations 
(Manera et al., 2014). Our study establishes that mouse skin MC status can be 
quantiﬁed at homeostasis using fractal geometry, image analysis and readily 
available standard bright ﬁeld microscopy on tissue sections routinely stained 
with MB, providing in situ quantiﬁcation of MC activation. We are currently 
applying similar approaches to complementary MC immunohistochemistry 
staining techniques designed to phenotype MC subsets. Introduction of the 
fractal theory in biology and medicine has already led to a better understanding 
of many physiological processes, including allosteric enzyme kinetics, 
intracellular bioenergetic dynamics, metabolic rate, drug clearance modeling, 
angiogenesis, cardiovascular physiology and tumor growth (Aon et al., 2008; 
Ferro et al., 2011; McNally and Mazza, 2010; Thamrin et al., 2010). Here we 
demonstrate in situ quantiﬁcation of MC status in mammalian tissue samples, 
combining relative density and fractal dimension measurements of MC 
cytoplasmic density and order. Furthermore, we propose that this morphometric 
analysis is applicable to patient samples and provide quantitative data pertaining 
to local MC activation in tissue sections in clinical settings. 
We demonstrate the ability to quantify in situ MC activation using 
computer-assisted image analysis and biological specimens, based on fractality 
and mass measurements. Reproducible, consistent and quantitative data were 
collected from multiple skin samples, establishing that signiﬁcantly different 
morphometric parameters are featured in intact and degranulated MC. This 
 29 
method may be further developed as a rapid diagnostic tool for the formulation of 
MC involvement in research and clinical settings.
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Figure 2.1 Methylene-blue stained mouse skin for MC detection and 
analysis. a: Methylene blue (MB)-stained mouse skin tissue section. Scale bar is 
200 μm. b: MB-stained mouse skin tissue section with a selection of two 
randomly selected and isolated mast cells (MC) (Scale bar = 50 μm); an intact 
MC and a degranulated MC. c: Isolated MC images are color-thresholded 
(orange), followed by measurement overlay (green) to allow for relative density 
and mass measurement IOD/A determinations.  
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Figure 2.2 Comparison of mass between intact and degranulated MC.  
Comparative relative density and mass measurements as integrated optical 
density (IOD) over Area (A) ratios for intact and degranulated MC in skin samples 
of four different normal mice (**p<0.001).  
 32 
 
 
Figure 2.3 Fractal dimension to identify intact and degranulated MC. Fractal 
dimension (D) is a morphological descriptor of chaos and space ﬁlling capacity of 
MC cytoplasm. a: For measurement of D, the digitized image in Figure 2.1b was 
thresholded to generate a black and white 8-bit gray scale image from the color 
image. b: Threshold images were generated using the free HarFa software, 
which includes several ﬁltration algorithms to eliminate thermal noise associated 
with the digital camera and illumination variations (gray scale) across the image. 
Scale bar is 50 μm.  
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Figure 2.4 Fractal dimension of degranulated MC is higher than intact MC. 
Comparative fractal dimension (D) analysis for intact and degranulated MC in 
skin samples of four different normal mice (14 images per animal were 
analyzed). Degranulation of MC increased the D values signiﬁcantly and 
consistently, compared to D values of intact MC (**p<0.001).
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CHAPTER 3: MAST CELLS AND SPHINGOSINE-1-PHOSPHATE UNDERLIE 
EARLY PATHOGENIC REMODELING IN PRE-LESIONAL ECZEMA2 
3.1 INTRODUCTION 
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease 
that affects 15-30% children and 2-10% adults world-wide (Auriemma et al., 
2013; Darlenski et al., 2014; Eyerich and Novak, 2013; Graham and Nadeau, 
2014; Liu et al., 2011; Nakamura et al., 2013; Patrizi et al., 2011; Szegedi et al., 
2015). This complex multifactorial disorder often features hypersensitivity to 
environmental agents and immune dysfunction (Auriemma et al., 2013; Elias, 
2014; Eyerich and Novak, 2013; Kim et al., 2014; Liu et al., 2011; Mu et al., 
2014; Patrizi et al., 2011). Yet, the sequential events leading to eczematous 
lesions and AD etiology are not completely understood. 
Interestingly, 70-80% of AD patients have increased levels of total serum 
IgE antibodies (Ando et al., 2013; Auriemma et al., 2013; Darlenski et al., 2014; 
Kendall and Nicolaou, 2013; Liu et al., 2011; Patrizi et al., 2011). Perivascular 
accumulation of lymphocytes and mast cells (MC) are observed in chronic 
lesions (Ando et al., 2013). However, few studies have investigated the initial 
phase leading to lesions, including events prior to IgE production (Gittler et al., 
                                            
2  Wedman, P., A. Aladhami, A. Chumanevich, J.W. Fuseler, and C.A. Oskeritzian. 2017. 
Mast Cells and Sphingosine-1-Phosphate Underlie Early Pathogenic Remodeling in 
Prelesional Eczema. Under Revision. Allergy, 03/29/2017.  
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2012; He et al., 2007; Kim et al., 2014; Spergel et al., 1998; Wang et al., 2007; 
Zhu et al., 2015). Equipped with surface receptors for IgE (FcεRI) and other 
ligands and tissue-resident at homeostasis, MC play an important role as 
initiators of inflammation and first-line responders to inflammatory signals (Griffith 
et al., 2014; Oskeritzian, 2015; Oskeritzian et al., 2015; Oskeritzian et al., 2010). 
Moreover, MC present the unique ability to produce and store many vasoactive 
and cytoactive mediators in their cytoplasmic granules prior to trauma and also 
neo-synthesize bioactive products upon activation (Galli and Tsai, 2012; 
Kalesnikoff and Galli, 2008; Mu et al., 2014; Nakamura et al., 2013; Oskeritzian, 
2015; Oskeritzian et al., 2015; Oskeritzian et al., 2010; Zhu et al., 2015). We 
recently established that MC and a potent sphingolipid metabolite, sphingosine-
1-phosphate (S1P) are at the nexus of inflammatory infiltration in early lung 
allergic responses (Oskeritzian et al., 2015). We previously reported that MC-
derived S1P, produced by sphingosine kinase (SphK), can be exported out upon 
activation, amplify MC cytokine/chemokine production by autocrine binding to 
S1P receptors and regulate cell trafficking (Mitra et al., 2006; Oskeritzian, 2015; 
Oskeritzian et al., 2008; Oskeritzian et al., 2015). S1P can also activate MC 
independently of the canonical IgE/FcεRI pathway (Chumanevich et al., 2016; 
Kendall and Nicolaou, 2013; Oskeritzian et al., 2015; Oskeritzian et al., 2010). 
In the current study, we investigated AD pathogenesis using a variation of 
a well-established human AD-like mouse model and collected skin samples for 
analysis after a single epicutaneous (EC) exposure to OVA Ag (Spergel et al., 
1998). We discovered a new pathogenic pathway leading to AD that links cell 
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infiltration of the hypodermis to local MC activation and S1P elevation. Next, we 
examined skin remodeling in mice deficient for SphK1 or MC and after LPS-free 
OVA exposure and established an essential role for MC, S1P and LPS at the 
onset of AD. 
3.2 MATERIALS AND METHODS 
Atopic dermatitis model 
AD was induced in 8 to 12 weeks of age-matched female C57Bl/6J (WT), 
SphK1 KO (SphK1tm1Rlp), and MC-deficient KitW-sh/W-sh (B6.Cg-KitW-
sh/HNihrJaeBsmGlliJ) mice as previously described (Spergel et al., 1998), 
purchased from Charles River NCI (Frederick, MD) and The Jackson Laboratory 
(Bar Harbor, ME). After simple randomization using shuffled pieces of paper that 
indicated saline, OVA or LPS-free OVA, mice were assigned to either 
experimental group. Then, 100 µl of OVA solution (100 µg OVA (Sigma-Aldrich, 
St Louis, MO) or LPS-free OVA (100 µg EndoGrade® OVA (Hyglos GmbH, 
Munich, Germany) in 0.9% saline) or 0.9% saline only (saline control) were 
pipetted on a 1 cm x 1 cm square gauze pad (patch) placed on the shaved and 
tape-striped upper-back skin area. Next, this area was occluded with a Tegaderm 
Transparent Dressing (3M HealthCare, St Paul, MN) using bandages. Patch was 
removed after seven days and skin samples collected from euthanized mice. For 
patch 3-IgE determinations, the full AD protocol was conducted exactly as 
previously described (Spergel et al., 1998). Briefly, each patch was secured for 
one week followed by two weeks of rest before next exposure week. Patch 1 and 
patch 3 sera were prepared from blood collected by cardiac puncture 
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immediately after euthanasia and stored at -80oC until use. Animal experiments 
and all experimental protocols were approved by the University of South Carolina 
Institutional Animal Care and Use Committee. Animal experiments and all 
methods were performed in accordance with the relevant guidelines and 
regulations. 
Histology and Microscopy 
Skin tissues collected from euthanized mice were fixed in 4% fresh 
paraformaldehyde. Fixed tissues were embedded in paraffin, sectioned (4 µm 
thickness) and mounted on microscope slides. One group of slides was stained 
with Hematoxylin and Eosin (H&E) for skin morphometric analysis. To visualize 
MC, a second group of slides was placed in 0.1% methylene blue (MB) for five 
seconds, rinsed with water, dehydrated in 100% ethanol and mounted under 
coverslips with cytoseal 60 (Wolters et al., 2005). Sections were imaged with a 
Nikon E-600 microscope (Nikon Inc., Melville, NY) equipped with a 
Micropublisher digital camera model 5.0 and images collected as TIFF files with 
the Micropublisher software at low (10x, numerical aperture 0.30) and high (40x, 
numerical aperture 0.75) magnification for analysis. Images were analyzed as 
24-bit color images or 8-bit monochrome images, as required, using the 
QImaging software version 2.0.13 (QImaging Corp., Surrey, BC, Canada). 
Morphometric and fractal parameters of nuclei (infiltration, 25-30 ROIs/image, a 
minimum of twelve 40x-images/skin section; 4 skin sections/2 mice/treatment 
group) and MC (percent degranulation, fifty 40x- total images/310-485 total MC; 
4 skin sections/2 mice/treatment group) were measured using the MetaMorph® 
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6.1 Microscopy Automation and Image Analysis software (Molecular Devices, 
Sunnyvale, CA) and the free HarFa imaging software 
(www.fch.vutbr.cz/lectures/imagesci/), as previously described (Wedman et al., 
2015).  For these and all quantifications described below, the investigators who 
were making measurements were blind to slide group allocations (single blind 
studies). 
Morphometric measurement of skin remodeling 
The thickness of each skin layer (epidermis, dermis and hypodermis) was 
measured in saline- and OVA-treated specimens using an ocular micrometer 
(Klarmann Rulings, Inc., Litchfield, NH). From each slide, uniform regions of the 
epidermis, dermis and hypodermis were selected and the average thickness was 
measured (n= 3-5 measurements/3-5 animals/treatment group/skin layer (i.e, 
epidermis, dermis, hypodermis).  
Computer-assisted quantification of hypodermal cellular infiltration 
A recent computer-assisted imaging method developed by our laboratory 
(Wedman et al., 2015) was adapted to quantify cellular infiltration. A minimum of 
twelve high-magnification H&E images per animal was used to determine cellular 
infiltration in the hypodermis. To this end, nuclei were isolated by means of color 
thresholding using the set color threshold subroutine of the MetaMorph software 
(orange color overlay) and quantified by applying a fixed circular region of 
interest (ROI, diameter=75µm) of constant area that was moved sequentially to 
adjacent regions to survey the entire hypodermis of each section (n=25-30 
ROIs/section, 2 sections/slide, 2 slides/animal, 2 animals/treatment). The 
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morphometric parameters of the nuclei (area, perimeter and integrated optical 
density determined using the Integrated Morphometry Analysis subroutine of 
MetaMorph) were used to refine nuclei measurements and eliminate any 
background noise. 
Validation of cellular infiltration quantification by independent fractal 
dimension analysis  
As described above, fixed circular ROIs were isolated and collected as 
TIFF file images throughout the hypodermis of H&E images in each section. The 
hue, saturation and intensity values were adjusted to isolate the nuclei in orange 
as a thresholded region. The images of the individual isolated and selected 
nuclei (green) were converted to a 8-bit gray scale image for further fractal 
dimension measurements using the free HarFa imaging software 
(www.fch.vutbr.cz/lectures/imagesci/), which converts the gray-scaled image into 
a binary one, as we previously described (Wedman et al., 2015). Briefly, an area 
featuring cellular infiltration is an irregular and complex object composed of 
nuclei, which are fundamentally similar (self-similar). Because of its complexity, 
infiltration cannot be described by regular Euclidean geometry that uses integer 
descriptors (Brown et al., 2002; Wedman et al., 2015). Instead, it can be 
described quantitatively by fractal geometry using non-integer numbers, with 
values falling between two-integer topological dimensions (Mandelbrot, 1983; 
Smith et al., 1996). These non-integer numbers define the fractal dimension (D) 
of an “object”, here, the distribution of nuclei within a hypodermal ROI. As 
discussed previously (Wedman et al., 2015), the concept of fractals provides a 
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useful method to quantify the inherent irregularity or complexity of phenomena. In 
the case of the two-dimensional images analyzed in the current study, the values 
of D characterizing cellular infiltration are therefore fractional and lie between the 
Euclidean integers of 1 and 2.  
In situ determination of mast cell degranulation 
The MC granular cytoplasm is an irregular and complex object composed 
of proteoglycan-containing granules at different levels of resolution that are 
functionally and physiologically similar (self-similar). Thus, it can be considered 
as a fractal object and analyzed accordingly. Using this approach, we previously 
demonstrated (Wedman et al., 2015) that MC cytoplasm cannot be characterized 
by regular Euclidean geometry because of its complexity of form but can be 
described quantitatively as degranulated or intact by fractal geometry and 
dimension (Mandelbrot, 1983; Smith et al., 1996), with values ranging between 1 
and 2. We previously established that the fractal dimension (D) value uniquely 
characterizing intact MCs is 1.378 ± 0.062 and the D value describing 
degranulated MCs is 1.484 ± 0.048 (Wedman et al., 2015). These values were 
used as a baseline for non-subjective quantification of intact and degranulated 
MC numbers in the skin samples of saline- and OVA-treated animals (n=2 
animals/treatment). 
Quantitative Real-Time qPCR 
Skin samples were collected, snap-frozen and stored at -80oC until RNA 
extraction. Total RNA from saline-treated skin samples (n=4-8 animals) and 
OVA-treated skin samples (n=6-10 animals) was isolated and purified with the 
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miRNeasy kit (Qiagen, Valencia, CA), following the manufacturer’s procedure. 
The iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) was used according to 
the manufacturer’s specifications to reverse transcribe cDNA. QPCR was 
performed on a CFX Connect (Bio-Rad) with SensiFAST™ SYBR No-ROX Kit 
(Bioline, Taunton, MA). Primer sets used in real-time qPCR amplification are 
displayed in Table 3.1. The real-time qPCR conditions were as follows: initial 
step at 95°C for 5 min and cycles (n=40) consisted of 10 s at 95°C, followed by 1 
min annealing at 55°C and extension at 72oC. All reactions were performed in 
duplicate. Data were analyzed with CFX Manager™ Software and are 
normalized expression to saline-treated samples and directly proportional to the 
amount mRNA of the target gene relative to the amount of mRNA of the 
reference gene, GAPDH mRNA levels. Primers were purchased from Thermo 
Fisher Scientific, Inc. (Waltham, MA).  
Multiplex Assays 
The following chemokines were measured in mouse serum or in mouse 
skin protein extracts (n=10-12 mice/treatment/sample type) with a Bio-Plex Array 
Reader (LUMINEX 100; Bio-Rad Laboratories, Hercules, CA) with murine 
Milliplex panels (EMD Millipore, Billerica, MA): CCL2/monocyte chemoattractant 
protein 1, CCL3/macrophage inflammatory protein 1α and CCL5/RANTES. 
Mouse skin protein extracts were obtained from skin specimens harvested after 
one week of exposure to OVA or saline, weighed, and frozen in liquid nitrogen. 
Each sample was homogenized with a mortar and pestle and digested for 2 h at 
4°C in Reporter lysis buffer (Promega, Madison, WI) supplemented with 
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complete mini-protease inhibitor tablets (Roche Diagnostics, Indianapolis, IN). 
Supernatants were stored at −80°C and quantified for chemokine content, as 
indicated above. 
Total Serum IgE ELISA 
Mouse total serum IgE was measured by ELISA, according to 
manufacturer’s instruction (R&D Systems, Minneapolis, MN). N=6 
animals/experimental groups for one exposure and n=9 animals/experimental 
groups for three exposures. 
Lipidomics 
Lipids were extracted from snap-frozen skin tissues and S1P was 
measured by using liquid chromatography-electrospray ionization-tandem mass 
spectrometry (4000 QTRAP; AB Sciex, Foster City, CA), as previously described 
(Hait et al., 2009). Quantification of S1P was normalized to weight of skin 
sample. N=3-4 samples per experimental group. 
Statistics 
Data are expressed as means + SEM (unless otherwise stated) and were 
analyzed by using the unpaired 2-tailed Student t test, with Welch’s correction for 
samples of unequal variance (Prism 6; GraphPad Software, La Jolla, CA). 
Significance for all statistical tests is shown in figures. Experiments were 
repeated at least 3 times in triplicates with consistent results. In vivo experiments 
were repeated 3 times, and each experimental group consisted of 5 to 6 mice. 
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3.3 RESULTS AND DISCUSSION 
OVA triggers rapid skin remodeling and cellular infiltration  
We previously reported that systemic Ag stimulation leads to early lung 
remodeling in sensitized mice (Oskeritzian et al., 2015). These studies prompted 
us to revisit the development of another inflammatory disease of atopic nature, 
AD, for which the initiating mechanisms remain ill-understood (Leung and 
Guttman-Yassky, 2014; Malajian and Guttman-Yassky, 2015). We found that 
epidermal and dermal thickening that is observed in the 49-day AD mouse model 
(Spergel et al., 1998; Wang et al., 2007), was already significant albeit modest 
after one OVA application, compared to one saline treatment (Figures 3.1a-c). 
We observed a marked cellular infiltration in the hypodermis, compared to 
saline controls (Figures 3.1a-c). We adapted our recently established image 
quantification method (Wedman et al., 2015), to measure cellular infiltration 
(Figure 3.1d) in a defined region of interest (ROI) (circle in Figure 3.1e) 
sequentially moved across the entire hypodermis. Figure 3.1g shows whole 
hypodermis survey of infiltration in a representative saline-treated skin sample 
compared to an OVA-treated one, in which blood vessel (Bv)-containing ROI are 
depicted in red. Saline treatment triggered some infiltration, increased around Bv. 
The OVA application drastically increased hypodermal cell numbers, also around 
Bv (Figure 3.1g). The statistical validation of these results was demonstrated by 
analyzing multiple samples (Figures 3.1f, h). 
Having previously established the relevance of fractal dimension to define 
morphometric descriptors (Wedman et al., 2015), we reasoned fractals or 
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measures of space filling capacity could also represent an accurate method to 
quantify cellular infiltration. Figures 3.1i-j describe the procedure established to 
isolate nuclei/cells. Next, binary images (Figure 3.1k) were generated to calculate 
fractal dimensions (D) of ROI by quantifying the structural density of the “objects” 
(nuclei) or cellular infiltration. Figure 3.1l independently confirmed the increased 
cellular infiltration substantiated in Figures 3.1f-h after OVA treatment as 
measured by D values of multiple skin samples. The discriminatory performance 
of D was further validated in Figure 3.1m, also showing increased infiltration 
around the BV.   
Importantly, the present study analyzed prelesional skin specimens, 
therefore identifying novel histo-pathological mechanisms of pre-symptomatic 
AD. We described a new morphometric method to quantify rather than score 
cellular infiltration that uncovered a prevalent although previously unnoticed 
hypodermal infiltration after a single OVA treatment, suggesting an important 
function for the hypodermis at the onset of AD. We propose this initial infiltration, 
also reported in acutely inflamed airways (Oskeritzian et al., 2015), could 
constitute a novel target to prevent disease manifestation.  
OVA stimulates local and systemic chemokines 
We next investigated chemokine expression in treated skin samples 
collected from both treatment groups. Skin mRNA expression for CCL2, CCL3 
and CCL5, three members of the chemokine network we previously identified as 
major contributors to airway inflammation (Oskeritzian et al., 2015) were all 
significantly increased after OVA exposure (Figure 3.2a). Interestingly, skin CCL2 
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(Figure 3.2b) and CCL3 (Figure 3.2c) (but not CCL5 (data not shown)) protein 
levels were also increased upon OVA application, compared to saline controls. 
As expected, circulating chemokine levels did not exactly corroborate local 
levels. Serum CCL2 levels remained unchanged after EC OVA (Figure 3.2d), 
whereas serum CCL3 and CCL5 were enhanced (Figures 3.2e-f). Recently, a 
meta-analysis also described increased chemokine mRNA expression in patients 
with AD (Ewald et al., 2015). CCL2 and CCL3 genes were also identified in 
patients with moderate-to-severe AD by next-generation RNA-sequencing 
(Suárez-Fariñas et al., 2015). Combined with our finding, these studies also 
suggest an important role of infiltration in the establishment of AD. 
OVA exposure elicits significant IgE-independent skin MC degranulation and 
S1P elevation 
Further interrogating skin gene expression, we found that mRNA coding 
for the α chain of FcεRI (FcεRIα) was significantly up-regulated in OVA-treated 
mouse skin samples (Figure 3.3a). Importantly, the α chain is responsible for IgE 
binding to its receptor and initiates MC activation during allergic responses 
(Metzger et al., 1986). Although expressed by Langerhans (Haas et al., 1993) 
and other cells (Ying et al., 1998), we reasoned that skin-resident MC could also 
contribute to the enhanced FcεRIα mRNA detection in these samples. 
Microscopy examination of methylene blue (MB)-stained skin sections revealed 
that metachromatic MC were distributed throughout the skin layers, irrelevant of 
treatment (Figures 3.3b-c). Using our previously reported MC morphometrics, 
skin sections were analyzed for MC activation (Wedman et al., 2015). Figures 
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3.3b-c show representative examples of resting (green-framed insert, circle and 
arrow) MC and degranulated (red-framed insert, circle and arrow) MC. MC 
activation was morphometrically measured in whole hypodermis of samples to 
calculate the percentage of MC degranulation. Figure 3.3d demonstrated that 
skin MC were significantly more degranulated after OVA than after saline 
application. While it has been shown that AD features increased perivascular MC 
(Damsgaard et al., 1997; Kawakami et al., 2009), MC numbers were unaltered in 
either treatment in the current study (data not shown). Of note, a recent report 
delineated a protective role for MC during the development of spontaneous AD-
like disease in a transgenic mouse model but did not measure local skin MC 
activation (Sehra et al., 2016). Our finding of increased in situ MC degranulation 
at this early subclinical stage of AD was novel and intriguing. As expected, seven 
days of OVA exposure did not suffice to enhance circulating IgE levels (Figure 
3.3e), compared to its abundant detection after 3 OVA treatments (Figure 3.3e) 
as originally described (Spergel et al., 1998).  
MC can be activated by S1P, an influential sphingolipid metabolite 
resulting from the phosphorylation of its precursor sphingosine by SphK 
(Chumanevich et al., 2016; Oskeritzian et al., 2008; Oskeritzian et al., 2015; 
Oskeritzian et al., 2010; Rivera et al., 2008). Quantitative lipid analysis of skin 
samples, using lipidomics mass spectrometry (Hait et al., 2009), revealed that 
S1P was significantly increased in mouse skin after one exposure to OVA, 
compared to saline controls (Figure 3.3f). In agreement, SphK1 skin mRNA 
expression was also augmented after a single OVA application (Figure 3.3g). We 
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have shown that S1P-mediated MC activation led to the release of cell recruiting 
chemokines (Oskeritzian et al., 2008; Oskeritzian et al., 2015; Oskeritzian et al., 
2010; Price et al., 2013) and MC may serve as a local source of S1P (Mitra et al., 
2006; Oskeritzian et al., 2008), including when activated by mechanical stress 
such as tape-stripping, and induce leukocyte rolling in inflamed mouse venules 
and human endothelial cells (Nussbaum et al., 2015). MC are established 
chemokine producers in the chronic phase of AD (Griffith et al., 2014; Zhu et al., 
2015) and mediate leukocyte recruitment (Gonzalo et al., 2007; McAlpine et al., 
2012; Ohsawa and Hirasawa, 2012; Oskeritzian, 2015; Wu et al., 2013), although 
dispensable in a genetic mouse model (Sulcova et al., 2015). In the present 
study, it is noteworthy that local chemokine detection and MC activation occurred 
prior to IgE production. While augmented in most AD patients (Ando et al., 2013; 
Liu et al., 2011; Patrizi et al., 2011), our data suggest that IgE may contribute to 
AD progression rather than initiation. Importantly, our results strongly support MC 
and S1P as early contributors to the development of pre-AD-related skin 
alterations.  
SphK1 or MC deficiency protects against OVA-driven skin remodeling and 
infiltration 
To determine the relevance of S1P in the observed pre-symptomatic skin 
changes, we repeated the adapted AD protocol in SphK1 KO mice (Allende et 
al., 2004), of genetic background similar to the WT mice we used so far (Figures 
3.1-3.3). SphK1 deficiency mitigated OVA-initiated skin remodeling (Figures 3.4a 
vs. 3.1c). The SphK1-null hypodermis surveying revealed a slight but significant 
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increase in nuclei (i.e., cell) numbers after OVA, compared to saline-treated skins 
(Figure 3.4b), that was less pronounced than in SphK1-sufficient mice (Figures 
3.4b vs. 3.1f) and absent around the Bv (Figures 3.4c vs. 3.1h). Consistent with 
these results, the pattern of OVA-restricted chemokine gene induction in 
corresponding WT skin samples (Figure 3.2a) was not observed in SphK1 KO 
mouse skins (Figure 3.4d). Importantly, genetic ablation of SphK1 prevented 
OVA-initiated local up-regulation of FcεRIα mRNA expression (Figures 3.4d vs. 
3.3a) and skin MC degranulation (Figures 3.4e vs. 3.3d). These results strongly 
suggest that S1P is a driving mediator of IgE-independent skin remodeling and 
infiltration through local skin MC degranulation in AD pathogenesis.  
To investigate MC’s contribution to skin remodeling, we conducted OVA or 
saline EC exposure of MC-deficient KitW-sh/W-sh (Grimbaldeston et al., 2005) mice. 
Although some epidermal thickening was observed, KitW-sh/W-sh dermal layers 
were unaltered (Figure 3.4f), compared to MC-sufficient mice of similar genetic 
background (Figure 3.1c). Furthermore, MC deficiency prevented cellular 
infiltration of the hypodermis (Figures 3.4g-h), suggesting a critical role of MC in 
skin inflammatory responses. This was further confirmed by the absence of OVA-
induced up-regulation of chemokine, FcεRIα and SphK1 mRNA levels (Figure 
3.4i). It is noteworthy that skin-associated S1P levels were significantly lower and 
not increased upon OVA application in KitW-sh/W-sh mice (Figure 3.4j), compared to 
the corresponding WT mice (Figure 3.3f), supporting skin MC as a relevant local 
source of S1P. 
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Thus, it is tempting to speculate that MC may act as causative agents of 
inflammatory response of the skin, similar to our recent report pertaining to lung 
allergic responses (Oskeritzian et al., 2015). Moreover, local elevations of S1P in 
inflamed skins may contribute to early MC activation at the inception of AD, 
perhaps prompting MC themselves to further produce S1P. Keratinocytes 
(Oizumi et al., 2014) and Langerhans cells (Japtok et al., 2012) could also 
contribute to local S1P release. Nonetheless, our results suggest an important 
function for MC activation at the onset of AD, linking S1P and chemokines to 
early skin remodeling, thus setting the stage for the progression to AD. 
Decreased S1P in human AD has been evoked but not measured (Japtok et al., 
2014). In agreement with previous studies (Dillahunt et al., 2013; Oskeritzian et 
al., 2008), our data evoke a strong interdependency not only between 1) the 
presence of SphK1 and skin MC activation but also 2) skin S1P level alterations 
and the presence of MC. Thus, our study evokes local S1P and MC as potential 
triggering components of skin remodeling in early AD. 
Cellular infiltration, MC activation and local S1P elevation are abrogated in 
mice treated with lipopolysaccharide (LPS)-free OVA 
Yoon et al. recently established that endogenous TLR4 ligands are 
essential to epidermal thickening observed in EC-sensitized skin after tape-
striping (Yoon et al., 2016). Furthermore, commercial-grade OVA, used in this 
and most studies, contains high LPS levels, a TLR4 ligand (Watanabe et al., 
2003). To investigate the LPS contribution to the early skin inflammation upon 
EC OVA exposure, experiments were repeated using LPS-free OVA. EC LPS-
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free OVA-triggered hypodermal infiltration was similar to the one observed in 
saline-treated animals (Figures 3.5a-b). Moreover, local MC were not activated 
(Figure 3.5c) and S1P and SphK1 mRNA levels remained unaltered following 
LPS-Free OVA exposure (Figures 3.5d-e). These results suggest that the LPS 
co-administered with OVA Ag participated in the early skin inflammatory 
responses. This makes sense as most environmental Ag penetrate the body 
likely combined with LPS, thus mimicking natural Ag exposure. Several studies 
have investigated the effect of LPS “contamination” of OVA in allergic responses. 
While some studies reported that LPS/TLR4 signaling prime pro-inflammatory 
responses to OVA (Dong et al., 2009; Eisenbarth et al., 2002), others described 
protective effects of LPS in airway allergic responses (Watanabe et al., 2003). 
Our study is the first to compare the effects of OVA to LPS-free OVA in a mouse 
model of skin inflammation. Furthermore, our results suggest that LPS exposure 
may prime initial inflammatory responses, as recently suggested (Yoon et al., 
2016), and promote local MC activation and endogenous S1P production. Of 
note, topical exogenous S1P administration attenuated contact dermatitis in a 
hapten-induced murine AD-like model (Reines et al., 2009) and topical 
application of Fingolimod (FTY720), a structural analog of sphingosine also 
phosphorylated by SphK that acts as an S1P receptor agonist, could attenuate 
skin inflammation (Sun et al., 2016). Thus, we propose that endogenously 
produced S1P can exert varied pro-inflammatory functions, compared to 
exogenously applied, anti-inflammatory S1P.   
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The small but statistically significant structural and molecular alterations 
between saline and OVA treatment were expected, as these pathogenic events 
occurred prior to any overt sign of disease. Therefore, these primary and newly 
uncovered responses could not be compared to the large differences often 
reported when comparing acute to chronic AD skin lesions and further 
emphasize the relevance of our findings to pre-symptomatic AD pathogenesis. 
These initial signs of skin remodeling set the stage to forthcoming clinical 
features of AD, including eczematous lesions observed later in this preclinical 
model (after 3 OVA exposures) and in human AD. These findings highlight 
perhaps new prophylactic approaches for this disease whose treatment 
management still remains a clinical challenge.
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Figure 3.1 Skin remodeling starts after a single epicutaneous exposure to 
OVA. (a-b) H&E staining of skin tissues exposed to saline (a) or OVA (b). Panels 
a-b are representative images. Original magnification, ×100. (c) Thickness of the 
epidermis, dermis and hypodermis layers, as measured in H&E-stained tissues. 
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For epidermis thickness, n = 18 (saline, empty bars), 19 (OVA, grey bars), for 
dermis, n = 10 and 25 and for hypodermis, n = 10 and 25 individual measurements 
collected from 3-5 animals/treatment group/skin layer. (d) Example of H&E stained 
skin section focusing on the hypodermis (red arrow, original magnification, ×400) 
in which (e) nuclei are color-thresholded (orange) and a fixed circular region of 
interest (ROI, black circle) defined. (f) Nuclei numbers per ROI of multiple saline 
treated mice, compared to OVAtreated mice. (g) Representative nuclei 
enumeration performed in each ROI (n = 25 ROI) throughout the hypodermis of 
one saline-treated mouse (empty circles) and of another exposedto OVA (filled 
circles). Red symbols refer to blood vessel (Bv)-containing ROI. (h) Infiltration 
analysis focusing around Bv. (i) Nuclei within ROI were color-thresholded as in (e) 
and enumerated (green). (j) Colored nuclei images were gray-scaled and (k) a 
binary image was software-created to calculate the fractal dimension (D) of each 
ROI. Panels i-k are representative images of an isolated ROI. (l) D of ROI in skin 
specimens treated with saline or OVA. (m) Similar determinations of D were 
performed focusing around Bv. For all ROI determinations, 25-30 ROIs/image, a 
minimum of twelve 40x-images/skisection; 4 skin sections/2 mice/treatment group 
were analyzed (f, h, l, m). Statistical differences were determined with unpaired 2-
tailed Student’s t test with Welch’s correction. Bar = 50 µm. *p = 0.0142, *** p = 
0.0004, **** P≤0.0001.  
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Figure 3.2 Chemokines are up-regulated after a single exposure to OVA. (a) 
CCL2, CCL3 and CCL5 mRNA levels in OVA-treated skin samples (grey bars), 
normalized to those in saline treated skins (empty bars) and quantified against 
GAPDH mRNA levels, n = 6 saline animals, 4-5 OVA animals with duplicate 
determinations. (b) CCL2 (* p = 0.0383) and (c) CCL3 protein levels in skin extracts 
(* p = 0.0356) (b, c) or serum (d, e: * p = 0.0255) and (f) serum CCL5 protein levels 
(* p = 0.0307) all collected from mice treated with saline or OVA. Protein 
determinations, n = 4 (saline) and 6 (OVA) with duplicate determinations. 
Statistical differences were determined with unpaired 2-tailed Student’s t test with 
Welch’s correction (a-f). *p ≤0.05, **p ≤0.01, except otherwise indicated; ns, not 
significant.  
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Figure 3.3 Mast cells degranulation and S1P levels increase in OVA-treated 
skin tissues. (a) Alpha chain for the high-affinity receptor for IgE mRNA levels in 
OVA-treated samples (grey bars), normalized to saline (empty bars) treated 
samples and GAPDH, n = 4 saline animals, 6 OVA animals with duplicate 
determinations (*** p = 0.0002). (b, c) Methylene blue-stained skin sections after 
saline (b) or OVA (c) treatment. Arrows and inserts show examples of intact (green) 
or degranulated (red) mast cells (MC). Panels b-c are representative images. Bar 
= 50 µm. (d) Percent MC degranulation determinations in saline- and OVA-treated 
samples (* p = 0.0352, fifty 40x- total images/310-485 total MC; 4 skin sections/2 
mice/treatment group). (e) Determinations of total serum IgE after one saline or 
OVA treatment (1 Patch), n = 6 animals/treatment group, averages of duplicate 
determinations and after three saline or OVA treatments (3 Patches), n = 9 
animals/treatment group, averages of duplicate determinations (*** p = 0.0001). (f) 
Sphingosine-1-phosphate (S1P) content of mouse skins after saline or OVA 
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treatment, n = 8 saline and 5 OVA samples. ** p = 0.0088 (g) Sphingosine kinase 
(SphK)1 mRNA levels in OVA-treated samples (n = 4), normalized to saline (n = 
3) with duplicate measurements (* p = 0.0152). Statistical differences were 
determined with unpaired 2-tailed Student’s t test with Welch’s correction.  
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Figure 3.4 Skin remodeling and chemokine expression are mitigated in mice 
deficient for SphK1 or mast cells: S1P-mediated skin mast cell degranulation 
and mast cell-dependent local S1P production. Thickness of the epidermis, 
dermis and hypodermis layers in SphK1 KO mice (vertical line patterns) measured 
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in H&E-stained skin tissues. For epidermis thickness, n = 15 (saline, white bars), 
15 (OVA, grey bars), for dermis, n = 15 and 13 and for hypodermis, n = 15 and 15 
individual measurements collected from 3 animals/treatment group/skin layer. (b) 
Nuclei numbers per ROI within the hypodermis of saline-treated, compared to 
OVA-treated SphK1 KO mice. (c) Nuclei numbers per perivascular ROIs after 
saline or OVA treatment (d) CCL2, CCL3, CCL5 and FcεRIα mRNA expression in 
OVA-treated (n = 3-4) compared to saline-treated (n = 4) SphK1 KO skins, 
normalized to GAPDH, with duplicate determinations. (e) Percent mast cell 
degranulation measured in MB-stained saline- or OVA-treated SphK1-KO mouse 
skin samples. (f) Thickness of the epidermis, dermis and hypodermis layers of 
KitW-sh/W-sh mice (side-patterned bars), measured in H&E-stained tissues (n = 
13-15 saline (white), 10-15 OVA (grey) individual measurements collected from 3 
animals/treatment group/skin layer. (g) Nuclei numbers per ROI within the 
hypodermis of saline-treated compared to OVA-treated KitW-sh/W-sh mice. (h) 
Nuclei numbers around perivascular ROIs. (i) CCL2, CCL3, CCL5, FcεRIα and 
SphK1 mRNA expression from OVA-treated normalized to saline-treated KitW-
sh/W-sh mouse skin samples, and to GAPDH, with duplicate determinations. (j) 
S1P content of KitW-sh/W-sh mouse skins after saline or OVA treatment (n = 4 
mice/experimental group). All measurements were conducted as described in 
Figures 3.1-3.3. Statistical differences were determined with unpaired 2-tailed 
Student’s t test with Welch’s correction (a-j). **** p < 0.0001.  
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Figure 3.5 Cellular infiltration, mast cell degranulation and S1P increase are 
abated in mouse back skins exposed to LPS-free OVA. (a) Nuclei numbers per 
ROI within the hypodermis of saline (empty bars)-treated compared to LPS-free 
OVA (horizontal-patterned grey bars)-treated mice. (b) Nuclei numbers per 
perivascular ROIs after saline and LPS-free OVA treatments. (a, b) 20 ROI/animal, 
3 mice/treatment. (c) Skin mast cell degranulation (%) measured in MB-stained 
saline- or LPS-free OVA-treated mouse skin samples. (d) S1P content of mouse 
skins after saline or OVA treatment. (c, d) n = 8 (saline), n = 12 (LPS-free OVA). 
(e) Skin SphK1 mRNA expression from LPS-OVA-treated (n = 6) normalized to 
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saline-treated (n = 6) mouse skin samples, and to GAPDH, with duplicate 
determinations. Statistical differences were determined with unpaired 2-tailed 
Student’s t test with Welch’s correction (a-e). All measurements were conducted 
as described in Figures 3.1-3.3.
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Table 3.1 Mouse qPCR primer sequences 
Target Forward sequence Reverse sequence 
Mu_Gapdh  CAGAAGGGGCGGAGATGAT AGGCCGGTGCTGCTGAGTATGTC 
Mu_Ccl2 CACTCACCTGCTGCTACTCA GCTTGGTGACAAAAACTACAGC 
Mu_Ccl3 GCCATATGGAGCTGACACCC TAGTCAGGAAAATGACACCTGGC 
Mu_Ccl5 TGCCCTCACCATCATCCTCACT GGCGGTTCCTTCGAGTGACA 
Mu_SphK1 CGTGGACCTCGAGAGTGAGAA AGGCTTGCTAGGCGAAAGAAG 
Mu_FcεRIα ATTGTGAGTGCCACCGTTCA GCAGCCAATCTTGCGTTACA 
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CHAPTER 4: A MAST CELL-MEDIATED ELEVATION OF CERAMIDES 
TRIGGERS APOPTOSIS IN PRE-LESIONAL ATOPIC DERMATITIS.3 
4.1 INTRODUCTION 
Atopic dermatitis (AD), also known as eczema, is one of the most common 
chronic diseases, featuring severe itch and skin lesions. AD affects one-fifth of 
individuals residing in developed countries (Weidinger and Novak, 2016). It is 
well established that a disrupted skin barrier plays an integral role in AD etiology. 
The stratum corneum (SC) is the outermost layer of the epidermis that prevents 
water loss and protects underlying tissues from external factors including 
allergens and pathogens. It comprises a lipid matrix of cholesterol, free fatty 
acids and ceramides (CER) (Elias, 2014; Janssens et al., 2012; Skolová et al., 
2014; van Smeden et al., 2011). 
CER are the most abundant SC lipids and play a critical role in 
maintaining homeostatic skin functions. Composed of a sphingoid base linked to 
a fatty acid chain, CER can be produced by three distinct pathways: the de novo 
synthesis pathway requires serine palmitoyl transferase and ceramide synthases 
(CerS) to generate CER, the salvage pathway involves degradation of complex 
sphingolipids to form CER, and subsequently sphingosine and sphingosine-1
                                            
3 Wedman P., Chumanevich A.P., Aladhami A., Castleberry K.M., Enos R.T., Gandy K.A., 
Velazquez K.T., Murphy E.A., Fuseler J.W., Nagarkatti M. and Oskeritzian C. A.. 2017. A 
Mast Cell-Mediated Elevation of Ceramides Triggers Apoptosis in Pre-Lesional Atopic 
Dermatitis. To be submitted to J Lipid Res. 
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phosphate (S1P), by ceramidases and lastly the sphingomyelin pathway which 
generates CER from sphingomyelin and sphingomyelinases (Aflaki et al., 2012; 
Grösch et al., 2012; Seumois et al., 2007). CER regulate a variety of 
cellularresponses including cell cycle arrest and apoptosis with specific behaviors 
being attributed to fatty acid chain length. CER are classified as short, long or 
very long chain, based on the number of carbons (C) they feature, C16-C24 
being the most common chain lengths (Seumois et al., 2007). Recent studies 
have highlighted the importance of CER chain length in skin barrier dysfunction, 
highlighting a decrease in very long chain C24 at the expense of long-chain C16 
during the chronic phase of AD (Janssens et al., 2012; Park et al., 2012). 
However, the status of CER during the early phase of AD has not yet been 
explored. 
In the current study, we investigated the pre-lesional CER composition of 
skin using a variation of a human-AD like mouse model after one 7-day exposure 
to Ovalbumin (OVA) or saline (vehicle control) to study disease initiation, the full 
model requiring 3 OVA exposures to induce chronic AD and skin lesions (Spergel 
et al., 1998). We found that EC OVA treatment of mouse skin resulted in 
significantly increased total CER levels, compared to saline controls. In 
particular, levels of C16 and C24 CER species were increased in OVA-treated 
samples. Elevated CER result from increased synthesis and/or decreased 
catabolism. Therefore, local mRNA expression of CER synthase (CerS) and 
ceramidase (Asah1/Asah2) was evaluated. CerS 4,5 and 6 but also Asah1 
mRNA levels were statistically augmented following OVA exposure. Given the 
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overall pro-apoptotic nature of CER, in situ activation of Caspase 3, the 
executioner Caspase of apoptosis, was measured using a novel image analysis 
method we describe to quantify cleaved Caspase-3 (Casp3) in treated skin 
sections, and validated by protein analysis. Since apoptosis may occur as a 
result of endoplasmic reticulum (ER) stress, skin samples were further 
interrogated for key molecules of ER stress-induced apoptosis. 
Mast cells (MC), skin-resident cells located near blood vessels, are well-
known key players in the initiation of atopic diseases and an established source 
of a variety of pro-inflammatory mediators secreted upon activation by many 
stimuli (Galli and Tsai, 2012; Oskeritzian et al., 2008; Oskeritzian et al., 2015; 
Oskeritzian et al., 2010). To substantiate the importance of MC in these 
processes, the AD model was repeated in MC-deficient Kit Wsh/Wsh mice. The 
absence of MC prevented OVA-induced CER increase and local apoptosis. 
Moreover, primary mouse bone marrow-derived MC (BMMC) activated by 
exogenous S1P at different time-points in vitro exhibited elevation of CER C16 
and C24 species with corresponding increased gene expression of CerS 4,5 and 
6 and Asah1.  We propose that the MC/CER axis is an essential pathogenic 
feature of pre-lesional AD. Targeting this axis may prevent disease development. 
4.2 MATERIALS AND METHODS 
Atopic dermatitis model 
AD was induced female C57Bl/6J mice as previously described (Section 
3.2). Mice were purchased from Charles River NCI (Frederick, MD) and The 
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Jackson Laboratory (Bar Harbor, ME). Animal experiments were approved and 
performed in accordance with IACUC guidelines. 
Lipidomics 
Lipids were extracted from snap-frozen skin tissues, as described in 
section 3.2, and S1P-activated BMMCs. CER were measured, and normalized to 
weight of skin sample or per 106 BMMCs. 
Quantitative Real-Time qPCR 
RNA was extracted from patched skin tissue, cDNA was synthesized and 
qPCR preformed as described in section 3.2. The primer sequences (Thermo 
Fisher Scientific) used for real-time qPCR amplification are located in table 4.1. 
Data were analyzed with CFX Manager™ Software and are normalized 
expression to saline-treated samples for in vivo experiments or 0 hour S1P 
activation for in vitro experiments and directly proportional to the amount mRNA 
of the target gene relative to the amount of mRNA of the reference gene, GAPDH 
mRNA levels.  
Immunofluorescent quantification of cleaved Caspase-3 
Skin tissues collected from euthanized mice were fixed in 4% 
paraformaldehyde, paraffin-embedded, sectioned (4 μm thickness) and mounted 
on microscope slides. Tissues underwent dewaxing, rehydration, antigen 
retrieval, blocking and permeabilization prior to overnight incubation with anti-
cleaved Caspase-3 antibody (CST, Danvers, MA). Secondary AlexaFluor 488 
donkey anti-rabbit IgG antibody (Jackson ImmunoResearch, West Grove, PA) 
was used to visualize cleaved Caspase-3. Images ((40x) magnification) were 
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collected as TIFF files and analyzed. Morphometric parameters were measured 
using the MetaMorph® 6.1 Image Analysis software (Molecular Devices, 
Sunnyvale, CA) as previously reported by our laboratory (Wedman et al., 2015), 
and adapted to quantify cleaved Casp3. 
Western blots 
Proteins were extracted from snap-frozen skin tissues and the Bradford 
protein assay was used to measure concentration. Equal concentrations of 
protein were electrophoretically separated on a 4-20% Mini-PROTEAN®TGXTM 
gel (Bio-Rad, Hercules, CA) followed by electrophoretic transfer to a 
polyvinylidene difluoride (PVDF) membrane. Membranes were incubated 
overnight with primary antibodies (Cleaved Caspase-3, CHOP, BiP and GAPDH; 
CST, Danvers, MA). Proteins were detected using an HRP-linked secondary 
antibody and captured on film. Signal was quantified using ImageJ software 
(NIH). 
Culture and activation of bone marrow-derived mast cells 
Mouse BMMC were generated from progenitors isolated from femurs and 
cultured in RPMI 1640 medium (Invitrogen Life Technologies, Carlsbad, CA) 
containing 10% heat-inactivated FBS, 2 mM L-glutamine, 1% antibiotics, 1 mM 
sodium pyruvate, 1 mM HEPES (Biofluids, Rockville, MD), 2 ng/ml recombinant 
IL-3 and 20 ng/ml of stem cell factor (SCF, PeproTech, Rocky Hill, NJ). After 4 
weeks of culture, BMMC were more than 98% pure and fully matured. S1P (100 
nM) was used to stimulate BMMCs for lipidomics and qPCR analyses.  
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Engraftment of MC-deficient mouse skin with BMMC 
Mature BMMC, generated from C57Bl/6 mice, were counted and 
resuspended in PBS (4 x 106 cells in 400 μl). BMMC were injected intradermally 
into back skin of anesthetized mice (8 x 50 μl injections in two rows down the 
length of the shaved back) (Kalesnikoff and Galli, 2011). Experiments were 
initiated 9 weeks after adoptive transfer of BMMC, allowing for proper 
reconstitution of skin MC. 
Statistics 
Data are expressed as means + SEM (unless otherwise stated) and were 
analyzed by using the unpaired 2-tailed Student t test, with Welch’s correction for 
samples of unequal variance or nonparametric Mann Whitney test (Prism 6; 
GraphPad Software, La Jolla, CA). 
4.3 RESULTS 
In atopic dermatitis, a single OVA exposure triggers an increase in 
ceramides. 
CER, the most abundant skin lipids, are known to be decreased in the SC 
during chronic AD, resulting in increased dryness and exposure to external 
environment (Park et al., 2013). We have recently shown that localized changes 
occur very early in response to allergic stimuli (Oskeritzian et al., 2015), thus we 
sought to investigate the status of CER at AD onset. Figure 4.1a shows that a 
single 7-day EC OVA exposure promoted CER production compared to saline-
treated controls. Pertinent CER species were highlighted upon CER profiling, 
with CER C16 and C24 species being most augmented (Fig. 4.1b). To determine 
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if the accumulated CER were produced de novo, we explored the gene 
expression of ceramide synthases (CerS). Figure 4.1c shows increased detection 
of CerS 4,5 and 6 but not CerS 1 or 2 mRNA in OVA-treated mice compared to 
Saline, normalized to Gapdh (black line). We also observed increased gene 
expression for the acid ceramidase, Asah1, but not the neutral ceramidase 
Asah2 (Fig. 4.1d). These results suggest that early accrual of CER C16 and C24 
stems from both synthetic and catabolic pathways.  
OVA exposure leads to increased detection of cleaved Caspase 3 
De novo production of C16 and C24 species has previously been linked to 
apoptosis in neutrophils (Seumois et al., 2007). Therefore, we next examined 
skin tissue sections for cleaved Casp3. Figure 4.2a shows a representative 
image of a fluorescently-labeled OVA-treated skin section. Using image analysis 
software, line scans were applied to detect positive signal while eliminating auto-
fluorescence (Fig. 4.2b and c). We have recently shown that morphometric 
parameters can be applied to quantify cellular changes in situ (Wedman et al., 
2015). Similarly, we established specific parameters for the quantification of 
cleaved Casp3 fluorescence. In figure 4.2d, we show that the computer proceeds 
with thresholding of positive signal and measurement (in green) while 
simultaneously eliminating background staining (orange). By measuring the ratio 
of integrative optical density (IOD) over the total image area, we show a 
significant increase in cleaved Casp3 following OVA exposure compared to 
saline-treated animals (Fig. 4.2e).  Presence of increased cleaved Casp3 was 
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further confirmed through Western blot analysis and quantification (Fig. 4.2f and 
g).  
ER-stress contributes to local apoptosis following OVA exposure 
Caspase 3, executioner enzyme of apoptosis, can be activated 
downstream of intrinsic signaling pathways during cellular stress. De novo 
synthesis of CER, by CerS, occurs within the ER (Futerman and Riezman, 2005) 
and increased production can trigger ER stress (Longato et al., 2012).  To 
determine if CER-induced apoptosis results from ER stress, we examined the 
skin tissues for stress-related markers. Local mRNA levels of binding 
immunoglobulin protein (BiP), activating transcription factor 4 (Atf4), x-box 
binding protein 1 (Xbp-1) and C/EBP-homologous protein (Chop) were all 
augmented following OVA exposure (Fig. 4.3a). Furthermore, significantly more 
CHOP (but not BiP) was detected by Western blot in OVA-treated skins 
compared to saline alone (Fig. 4.3b-d).  
OVA-induced increase in ceramides C16 and C24, and resulting apoptosis, 
is dependent on mast cells 
To substantiate how MC could contribute to ceramide regulation in vivo, 
we repeated similar experiments in MC-deficient KitW-sh/W-sh mice. Here we show 
that in the absence of MC, OVA exposure did not lead to ceramide accumulation 
(Fig. 4.4a and b) or changes in localized gene expression seen in WT mice 
(Fig.4.1c and d) for CerS 4, 5 and 6 or ceramidases (Asah 1 and Asah 2), in MC-
deficient KitW-sh/W-sh mice (Fig. 4.4c and d). Furthermore, no change in cleaved 
Casp3 was measured upon OVA treatment (Fig. 4.4e and f) in KitW-sh/W-sh mice. 
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To further confirm the importance of MC in CER-driven apoptosis, skin of KitW-
sh/W-sh mice was reconstituted through adoptive transfer of BMMC. Reconstituted 
mice were similarly treated with OVA and saline, as a control. Figures 4.4g and h 
show that protein production of cleaved Casp3 and CHOP was restored in OVA-
treated reconstituted mice. 
Bone marrow-derived MC, activated in vitro by sphingosine-1-phosphate, 
display a CER profile comparable to OVA-treated WT mice skin samples 
We recently highlighted the importance of S1P activation of MC in an 
acute pulmonary model of allergic response (Oskeritzian et al., 2015). Since we 
demonstrated that MC are required for early CER changes in the skin following 
OVA exposure, we next investigated if exogenous S1P would also trigger CER 
production in MC. In figure 4.5, BMMC were in vitro stimulated with S1P at 
different time points. Total CER were measured (Fig. 4.5a) and CER profiling 
was conducted (Fig. 4.5b) at 0, 6 and 16 hours following S1P activation. Total 
CER levels were time-dependently increased with CER C16, C22 and C24 
species being most prominent after 16 hours of stimulation. Further interrogation 
of BMMC showed increased gene expression of Cers 2, 4, 5 and 6 (Fig. 4.5c) 
and ceramidase Asah 1 (Fig. 4.5d) 3 hours following S1P stimulation, 
recapitulating the findings in mouse skin samples for the most part. 
4.4 DISCUSSION 
Ceramides are well known to play a role in chronic AD, but their function 
at AD onset is still unclear. Here, we report that ceramide accumulation can be 
observed in pre-lesional skin samples very early following a 7-day exposure to 
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OVA, compared to saline controls. OVA exposure resulted in significant elevation 
of total ceramides in particular, C16:0, C24:0 and C24:1 species. A recent study, 
conducted by YH Park et al., reported increased C16:0 at the expense of C24 
species in a preclinical model of chronic AD (Park et al., 2012). However, it is 
important to note that 1) they extracted lipids from the SC layer only, and 2) mice 
had skin lesions, which are absent in our 7-day model.   While ceramides are 
generally considered to be pro-apoptotic, it has been shown that C24 species 
can have protective effects (Grösch et al., 2012). As both pro-apoptotic C16 
(Mullen et al., 2011) and protective C24 species accumulated following one week 
OVA exposure, it is tempting to speculate that pro-survival mechanisms were in 
effect to return to homeostatic conditions. Of note, accumulation of both C16 and 
C24 ceramides has been observed within malignant tumors of head and neck 
squamous cell carcinoma and breast cancer patients compared with normal 
and/or benign tumor tissues, suggesting that the balance between C16 and C24 
species may control both apoptotic and survival pathways (Karahatay et al., 
2007; Schiffmann et al., 2009).  
In addition to increased ceramide levels, an increase in mRNA expression 
for ceramide-generating enzymes was also observed. Ceramide synthases 
(CerS) 1-6 link specific subsets of fatty acyl-CoAs to a sphingoid base generating 
ceramides with varying chain lengths, while ceramidases (acidic, neutral and 
alkaline) catalyze the cleavage of ceramides. Here we show increased 
expression of CerS 4,5 and 6. It has previously been shown that CerS 5 and 6 
are specific for long chain ceramides, including C16. CerS 4, the least studied 
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CerS, is considered to be a broad-spectrum CerS. Expression of CerS 4 has 
previously been linked to increased C24 ceramide species (Mizutani et al., 2009). 
Tirodkar et al. recently reported that elevation of CerS6 could mediate 
transcriptional activation of Asah1, which could explain the increased detection of 
acid ceramidase we observed following OVA exposure (Tirodkar et al., 2015). 
In this study, we report that topical OVA exposure induces an increase in 
C16 and C24 ceramide species compared to saline-exposed controls. Previous 
studies have linked de novo generation of C16 and C24 ceramides to 
spontaneous neutrophil apoptosis (Seumois et al., 2007) and tumor-induced DC 
apoptosis (Kanto et al., 2001). Similarly, we report that substantially increased 
C16 and C24 ceramides was linked to apoptosis, as measured by 
immunofluorescence staining of mouse skin sections upon OVA treatment. 
Detection of cleaved Casp3 was further validated and confirmed through 
quantification of cleaved Casp3 protein in OVA compared to saline-exposed skin 
samples using Western blot analysis. Thus, it appears the pro-apoptotic effects 
of C16 surpass protective C24 at the initiation of AD. 
When injury occurs, the ER stress response initiates survival pathways. 
The chaperone protein, BiP, dissociates from IREI, ATF6 and PERK activating 
the unfolded protein response (UPR). If the UPR fails, the ER-stress apoptosis 
pathway initiates, involving CHOP and the Caspase cascade (Chang et al., 
2013). Our results indicated BiP and transcription factors Atf4, Xbp1 and Chop, 
were increased in skin samples following OVA application, with confirmed 
elevation of CHOP protein, key mediator of ER stress-induced apoptosis. 
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We have shown the importance of MC during early allergic lung 
inflammation (Oskeritzian et al., 2015). Thus, we sought to investigate if MC were 
contributing to the augmentation of ceramides during early skin inflammation. In 
MC-deficient KitW-sh/W-sh mice, OVA application did not trigger ceramide elevation 
and cell survival was evident in the absence of cleaved Casp3. However, 
following MC reconstitution, cleaved Casp 3 levels returned to WT levels, also 
downstream of CHOP. Furthermore, we discovered that in vitro S1P activation of 
mouse BMMC stimulated ceramide production pathways leading to a comparable 
ceramide profile to the one observed in OVA-exposed WT mice skin samples. 
In conclusion, targeting S1P/MC interactions may be a novel prophylactic 
approach to prevent ceramide-mediated apoptosis at the onset of AD. 
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Figure 4.1 Skin exposure to OVA leads to increased ceramides in WT mice. 
A single, 7-day, OVA exposure resulted in elevation of total ceramides (a). 
Further analysis revealed specific increases in C16 and C24 ceramide species in 
OVA- compared to saline-treated mice (b). Elevated levels of mRNA for ceramide 
synthases (CerS) 4, 5 and 6 (c) and acid ceramidase (Asah1) (d) were observed 
in response to OVA.  
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Figure 4.2 Increased cleaved Caspase 3 is observed following OVA 
exposure. Cleaved capase-3 (Casp3) signal was analyzed in fluorescently 
labeled skin sections using a line scan histogram (a-c) and integrative optical 
density (IOD), which represents the mass or total amount of the fluorescent 
signal. Applying these parameters, images were thresholded to measure positive 
signal (d1, green). Significantly more cleaved Casp3 was quantified in situ in 
OVA-treated skins compared to saline (e). Protein analysis further confirmed 
production of cleaved Caspase 3 in OVA-treated skin samples (f-g).  
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Figure 4.3 OVA treatment leads to endoplasmic reticulum stress-induced 
apoptosis. Gene expression of key ER-stress regulators was upregulated 
following OVA treatment (a). A significant increase in Chop protein (b, n = 6 
mice/treatment group, c), but not Bip (b, d) was observed following OVA 
exposure.  
 77 
 
 
Figure 4.4 Ceramides, mRNA coding for genes involved in ceramide 
production remain unaltered and apoptosis undetectable upon OVA 
treatment of KitW-sh/W-sh MC-deficient mice. In the absence of MC, OVA 
exposure did not generate an increase in total ceramide levels (a), or in any 
specific ceramide species (b). The increased levels of mRNA for CerS 4, 5 and 6 
and Asah 1, seen in WT mice treated with OVA (Fig. 4.1c, d), were unchanged in 
similarly treated MC-deficient KitW-sh/W-sh mouse skin samples (c, d). Western blot 
band quantification (f) showed no difference in Casp3 cleavage in OVA- or 
saline-treated MC-deficient KitW-sh/W-sh samples (e, n = 4 mice/each treatment 
group). Casp3 activation was restored in OVA-treated KitW-sh/W-sh following MC 
reconstitution (g), concomitant with increased production of CHOP protein (h). 
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Figure 4.5 In vitro S1P stimulation triggers ceramide generation in BMMC. 
Increased production of total CER is observed after 16 hours of BMMC activation 
by S1P (a). Profiling highlights elevation of CER C16 and C24 species, also 
observed following OVA exposure in vivo (b and Fig. 4.1). Gene expression was 
significantly higher for CerS 2, 4, 5, 6 and Asah1 after 3 hours of S1P stimulation 
compared to untreated BMMC (c, d). 
 79 
Table 4.1 Mouse qPCR primer sequences 
Target Forward sequence Reverse sequence 
Mu_Gapdh  CAGAAGGGGCGGAGATGAT AGGCCGGTGCTGCTGAGTATGTC 
Mu_Cers1 CCACCACACACATCTTTCGG GGAGCAGGTAAGCGCAGTAG 
Mu_Cers2 ATGCTCCAGACCTTGTATGACT CTGAGGCTTTGGCATAGACAC 
Mu_Cers4 TACCCACATCAGACCCTGAAT TGAAGTCCTTGCGTTTGACATC 
Mu_Cers5 CGGGGAAAGGTGTCTAAGGAT GTTCATGCAGTTGGCACCATT 
Mu_Cers6 ATTCAACGCTGGTTTCGACAA TTCAAGAACCGGACTCCGTAG 
Mu_Asah1 CACCAGCGTTGAGGATTTTAGT TACCAGGCAGCTTTTGATCCA 
Mu_Asah2 GCAAAGCGAACCTTCTCCAC ACTGGTAACAAACAAGAGGGTGA 
Mu_Casp3  ATGGAGAACAACAAAACCTCAGT TTGCTCCCATGTATGGTCTTTAC 
Mu_Atf4 GGGTTCTGTCTTCCACTCCA AAGCAGCAGAGTCAGGCTTTC 
Mu_Chop CCACCACACCTGAAAGCAGAA AGGTGAAAGGCAGGGACTCA 
Mu_Bip TTCAGCCAATTATCAGCAAACTCT TTTTCTGATGTATCCTCTTCACCAGT 
Mu_Xbp1 GAACCAGGAGTTAAGAACACG AGGCAACAGTGTCAGAGTCC 
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CHAPTER 5: A MIRNA TRIAD EPIGENETICALLY REGULATES AD 
PATHOGENESIS 4 
5.1 INTRODUCTION 
Atopic dermatitis (AD) is a chronic inflammatory skin disease relieved by 
symptom management but with no cure. Skin-resident MC express many 
receptors, including the high affinity receptor for IgE (FcεRI) (Galli et al., 2008), 
which once cross-linked with Ag, initiates MC secretion of inflammatory 
histamine, cytokines and chemokines, many of which are pre-formed. IgE 
crosslinking also results in SphK1 activation, leading to the production of S1P, a 
multifunctional sphingolipid metabolite endowed with proinflammatory and 
chemotactic properties (Olivera et al., 2006; Oskeritzian et al., 2008). Once 
exported out of MC, S1P can ligate MC-expressed S1P receptors (S1PR) (Mitra 
et al., 2006; Oskeritzian et al., 2008; Oskeritzian et al., 2007). S1PR2 signaling 
amplifies local allergic responses through further MC stimulation and immune cell 
recruitment (Oskeritzian et al., 2015). We recently discovered that S1P ligation of 
S1PR2 on MC was a key driver of early inflammatory pathways in acutely 
inflamed lungs. Moreover, these studies identified a new MC-associated 
signaling pathway that encompasses activation of signal transducer and activator
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 of transcription 3 (Stat3) downstream of S1P/S1PR2, critical to MC-derived 
chemokine secretion (Oskeritzian et al., 2015). 
In recent decades, increased prevalence of AD was observed in 
developed countries. While research has identified genetic inheritability as one 
factor that contributes to AD manifestation, the rise in affected individuals cannot 
be attributed to genetic factors alone. With the discovery of miRNA, short non-
coding RNA that can post-transcriptionally modify gene expression, new studies 
began to investigate the epigenetic regulation of AD. Such studies have focused 
on  miRNA expressed in psoriasis and established AD (Sonkoly et al., 2007), 
while others have investigated that status of miRNA in skin (Sonkoly et al., 2010) 
and keratinocytes (Rebane et al., 2014) of AD patients bearing chronic lesions 
compared to healthy controls. However, miRNA alterations at the pre-lesional 
phase of AD has yet to be explored. 
We employed a well-established preclinical model that mimics human AD-
like disease progression and consists in three 1-week EC exposures to OVA, 
each separated by two weeks of rest (Spergel et al., 1998). We discovered that 
miRNA 34a, 485 and 486 were consistently down-regulated in skin samples 
exposed three times to OVA compared to saline-treated skins. In silico analysis 
of predicted target genes and pathways identified canonical cytokines and 
chemokines associated with AD anticipated to be de-repressed by decreased 
expression of these miRNA. Interestingly, SphK1 and Stat3 were also highlighted 
as target genes predicted to be up-regulated.  
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To investigate the relevance of this newly identified miRNA triad to AD 
pathogenesis, miRNA profiling was also performed on skin samples collected 
following a single OVA or saline exposure. Surprisingly, we observed that 
miRNA-34a, 485 and 486 were also significantly down-regulated at the early 
stage of AD, further highlighting their implications in disease development. 
5.2 MATERIALS AND METHODS 
Mice 
Aged- and gender-matched C57Bl/6 mice were shaved on the back and 
skin was tape-stripped prior to OVA or saline exposure, as previously described 
(Chapter 3) (Spergel et al., 1998). Skin samples were collected following the first 
and third exposures. 
RNA extraction 
Snap-frozen skin samples were homogenized and RNA was extracted 
using Qiagen miRNeasy kits, according to manufacturer’s instructions.   
MicroRNA expression profiling 
RNA samples collected following three exposures were sent to Johns 
Hopkins University Deep Sequencing and Microarray core (Baltimore, MD) for 
miRNA microarray analysis, using the Affimetrix Genechip MiRNA 3.0 array 
platform and oligonucleotide probe sets for 1,111 mouse mature MiRNAs from 
Sanger miRbase. Four skin samples were analyzed from two OVA-treated and 
two saline-treated mice (n= two independent experiments). MiRNA microarray 
profiling of RNA collected at AD onset (i.e. following a single exposure to OVA or 
saline) was conducted using the Affimetrix GeneChip miRNA 4.0 platform with 
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oligo probe sets for ~3,200 mouse miR (n=three independent experiments – OVA 
compared to saline) at the Microarray Core Facility, SC College of Pharmacy at 
USC Columbia. 
Computational pathway analysis 
Ingenuity Pathway Analysis (IPA) software (Ingenuity ® Systems) was 
used to identify target genes and pathways regulated by differentially expressed 
miRNA. 
Real time qPCR 
Total skin RNA were reverse transcribed to obtain cDNA using iScript 
synthesis kit (Bio-Rad). QPCR was completed using SensiFAST SYBR No-ROX 
kit (Bioline) on Bio-Rad CFX connect platform (see primer sequences in Table 
5.1). To validate the miRNA microarray analysis, cDNA generated with the 
miScript II RT Kit was used as a template for qPCR with the miScript SYBR 
Green PCR Kit and miScript Primer Assays, according to manufacturer’s 
instruction (Qiagen). 
5.3 RESULTS 
Skin miRNA profiles following repeated exposure to OVA 
In a preclinical model of AD consisting in repeated EC exposure to OVA or 
saline (controls)  (Spergel et al., 1998), we identified, by miRNA microarray 
analysis, a triad of miRNA consistently down-regulated following OVA exposure: 
miR 34a, 485 and 486 (Figure 5.1a). Figure 5.1b shows qPCR validation of these 
miRNA, confirming the significant reduction of expression in OVA-treated 
samples compared to saline, after normalization to Small Nucleolar RNA, C/D 
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Box 96A (Snord96a) control. Furthermore, analysis of predicted target genes 
using bioinformatics computational tools identified canonical mediators 
associated with AD, including IgE receptors (FcεRIα and FcεRIγ chains), 
cytokines and chemokines (Figure 5.1c), upregulated by decrease of these 
miRNA.  Further qPCR analysis confirmed increased expression of mRNA 
coding for CCL5, FcεRIα, and TNFα (Figure 5.1d). Of note, SphK1 and IL17a 
mRNA levels were not significantly altered. 
MiRNA profiling of skin following one OVA exposure 
Next, we sought to determine the contribution of these miRNA to the 
inception of AD as potential disease biomarkers and molecular targets. Figure 
5.2a shows the average fold change of miRNA in skin samples collected from 3 
independent in vivo experiments when comparing a single 1-week OVA exposure 
to saline controls. Mature miRNA may be generated from the 3’ or 5’ arms of pre-
miRNA precursors. To further establish the relevance of this miRNA triad to AD 
onset, both 3p/5p miRNA species were investigated. A significant decrease in 
miRNA-34a-3p and -486-5p was established by microarray analysis (Figure 5.2a) 
that did not reach statistical significance for miRNA-485-5p and -486-3p. 
Validation of the microarray data by qPCR established down-regulation of 
miRNA-34a-5p, -485-5p, -486-3p and-5p species (Figure 5.2b). Analysis of 
predicted target genes revealed significant elevation of FcεRIα, SphK1 and 
chemokines CCL5, CCL19, CCL21 and CCL22 (Figure 5.2c).  
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5.4 DISCUSSION AND FUTURE DIRECTIONS 
Little is known about the epigenetic regulation of AD. Among epigenetic 
modifiers, miRNA are small noncoding RNA that influence gene expression by 
inhibiting translation or inducing RNA degradation (Sonkoly et al., 2010). Using a 
preclinical AD model (Spergel et al., 1998), we discovered that three miRNAs, 
34a, 485 and 486 were consistently down-regulated in diseased compared to 
healthy skin samples. Moreover, in silico analysis of predicted target genes and 
pathways for these miRNA identified canonical cytokines IL-5, IL-17a (Auriemma 
et al., 2013) and chemokines CCL19, CCL21 (Kawakami et al., 2009; Millrud et 
al., 2014) associated with AD de-repressed by decrease of these miRNA. 
Interestingly, SphK1 and Stat3 were also triad-targeted. Because our lab focuses 
on unraveling early molecular events driving disease pathogenesis, the status of 
our newly discovered miRNA triad was evaluated following a single OVA 
exposure compared to saline control. Surprisingly, we found miRNA 34a, 485 
and 486 were also significantly down-regulated at AD inception.  
Sonkoly et al. reported the overexpression of miRNA-155 in chronic AD 
skin lesion compared to healthy human skin (Sonkoly et al., 2010).  Interestingly, 
they also described down-regulation of miRNA-486 in chronic human skin 
lesions. Rebane et al. evaluated miRNA expression in keratinocytes of chronic 
AD patients that featured upregulation of miRNA-146a expression. Of interest, 
miRNA-34a was also down-regulated in their study (Rebane et al., 2014). 
To further assess the functional contribution of these miRNA in vivo, 
down-regulation of these miRNA will be induced in saline-treated controls of our 
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AD preclinical model, using antisense oligonucleotides, antimiRs acting as 
miRNA inhibitors. Locked nucleic acid (LNA) modified oligonucleotides (LNA-
antimiR, Exiqon, Woburn, MA, compared to LNA-mismatch antimir control) will 
be utilized because they allow long-lasting in vivo miRNA inhibition (Stenvang et 
al., 2012). We anticipate that forcing down-regulation of these miRNA in control 
mice should recapitulate the remodeling, cellular and molecular findings of those 
obtained after OVA treatment. To monitor the anti-sense activity and effective 
miRNA inhibition, a functional read-out of miRNA silencing is recommended and 
will consist in measuring de-repression of direct targets by qPCR and protein 
assays (Western blots and ELISA) as an evidence for success. In a 
complementary approach, primary mouse and human MC will be transfected with 
miScript synthetic miRNA mimics (mimics and HiperFect transfection reagents 
from Qiagen) of each member of the miRNA triad separately or in combination. 
MC activation with S1P and subsequent chemokine production will be assessed 
in vitro and compared to non-transfected MC and MC transfected with mock 
mimics. We anticipate that miRNA overexpression will result in MC 
hyporesponsiveness.  
To our knowledge, the current study is the first to investigate the 
epigenetic regulation of early inflammatory events featured in pre-symptomatic 
AD. These results highlight an important group of miRNA, downregulated at 
disease onset and during chronic-stage skin inflammation. We show that these 
miRNA target relevant AD-associated cytokines and chemokines and also 
MC/S1P signaling-related FcεRI, SphK1 and Stat3 gene expression. These 
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results suggest that the contribution of skin MC-derived chemokines and S1P we 
observed at AD initiation (Chapters 3 and 4) may be epigenetically regulated by 
miRNA 34a, 485 and 486. 
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Figure 5.1 Down-regulation of skin miRNA up-regulates AD-associated 
gene expression.  A miRNA triad, composed of miRNA 34a, 485 and 486 is 
consistently decreased following 3 OVA exposures compared to saline-treated 
skin (n = 2 independent trials). Down-regulation of miRNA was validated and 
Ingenuity Pathway Analysis (IPA) software (Ingenuity® Systems) was used to 
identify predicted target genes, including cytokines and chemokines (pink), FcεRI 
receptor sub-units (purple), Sphingosine kinase 1 (SphK1, orange) and 
transcription factor Stat3 (red) (b,c). To test the biological relevance of in silico 
predictions, qPCR was used to determine the mRNA levels of some of the 
predicted target genes in OVA- compared to saline-treated skin samples, 
normalized to GAPDH (d).   
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Figure 5.2 A newly identified AD-associated microRNA signature is also 
relevant to AD pathogenesis with validated target gene de-repression. To 
determine their contribution to AD onset, status of triad members was analyzed 
following a single OVA exposure, compared to saline, (n = 3 independent trials) 
and validated by qPCR, confirming significant decrease in miR34a-5p, miR485-
5p, miR486a-3p and -5p (b). Gene expression for some disease-relevant 
predicted triad-targets was increased (c).  
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Table 5.1 Mouse qPCR primer sequences 
Target Forward sequence Reverse sequence 
Mu_IL17a  GCTCCAGAAGGCCCTCAGACT CCAGCTTTCCCTCCGCATTGA 
Mu_TNFα CCAGTGTGGGAAGCTGTCTT AAGCAAAAGAGGAGGCAACA 
Mu_Ccl19 GCCTGCTGTTGTGTTCACC CCTTTGTTCTTGGCAGAAGACT 
Mu_Ccl21 TGAGCTATGTGCAAACCCTGAGGA TGAGGGCTGTGTCTGTTCAGTTCT 
Mu_Ccl22 AGGTCCCTATGGTGCCAATGT CGGCAGGATTTTGAGGTCCA 
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CHAPTER 6: SUMMARY AND CONCLUSIONS 
6.1 MOLECULAR MECHANISMS UNDERLYING EARLY SKIN REMODELING AT 
THE ONSET OF ATOPIC DERMATITIS 
In 1998, Spergel et al. published a pre-clinical model of human-like AD. 
The model consists of shaving the back of the mouse and securing a patch 
containing ovalbumin (OVA, Ag) to the mouse for 3 consecutive 1 -week periods, 
each separated by two weeks of rest (Spergel et al., 1998). Our lab is most 
interested in investigating disease initiation, so we collected samples after the 
first 1-week exposure. Surprisingly, we observed skin thickening and increased 
cellular infiltration into the hypodermis during this early phase of inflammation. 
Quantitative image analysis revealed a significant increase in hypodermal nuclei 
following OVA exposure, most concentrated around blood vessels. Next, local 
and systemic levels of CD3+ T-cell recruiting chemokines were evaluated. We 
found that OVA-treated skin featured localized augmentation of CCL2, CCL3 and 
CCL5, chemokines we previously identified as key players of remodeling in Ag-
challenged airways (Oskeritzian et al., 2015).  
6.2 SPHINGOSINE-1-PHOSPHATE AND MAST CELLS CONTRIBUTE TO SKIN 
INFLAMMATION IN EARLY-PHASE ATOPIC DERMATITIS 
We conducted the first study that has identified that cellular infiltration 
initiated in the highly vascularized hypodermal skin layer. As previously 
mentioned, local resident MC reside within close proximity to Bv, allowing them
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 to play an active role in cell recruitment following release of chemokines. We 
established and published a method to evaluate MC activation status in situ by 
taking advantage of the metachromatic properties of methylene blue, which 
stains all nuclei blue while distinguishing MC from other cells through binding of 
granule-specific peptidoglycans resulting in purple coloration. MC status was 
evaluated in skin tissue collected from naïve C57Bl/6 mice and we identified a 
spectrum of morphometric parameters that could distinguish resting from 
degranulated MC in situ following a computer-assisted procedure. Applying these 
parameters to OVA-challenged skin samples highlighted a significant increase in 
localized MC degranulation compared to saline controls. MC are canonically 
activated through IgE/Ag stimulated pathways. However, we confirmed that a 7-
day OVA exposure did not elicit augmented levels of total IgE, as Ab production 
takes 10-14 days. Moreover, mRNA expression of S1P producing enzyme 
SphK1, was significantly increased in skin of OVA-treated mice compared to 
saline controls and lipidomics analysis revealed a corresponding increase of 
S1P. SphK1 knockout and MC-deficient KitWsh/Wsh mice failed to exhibit skin 
remodeling, hypodermal infiltration and associated chemokine production, 
following OVA exposure. Moreover, MC-deficient mice did not feature 
augmentation of S1P, identifying MC as a local source.  
Interestingly, the very group from Harvard who established the AD mouse 
model, used by us and many other groups world-wide, recently reported that 
tape-stripping, a procedure included in the animal protocol that mimics the 
scratching response of human patients, resulted in the release of endogenous 
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TLR4 ligands (Yoon et al., 2016). Commercially available OVA is notorious for its 
high content of TLR4-binding lipopolysaccharide (LPS). Our study is the first to 
compare the effects of OVA to LPS-free OVA in a mouse model of skin 
inflammation. Contrary to what we expected, based on a study describing the 
protective effects of LPS in airway allergic responses (Watanabe et al., 2003) 
and another finding high LPS exposure protected Amish children from high 
occurrence of allergic disorders affecting genetically-related Hutterite children 
(Hutterites using industrialized  more aseptic farming methods compared to 
Amish people who use traditional farming methods) (Stein et al., 2016), local MC 
activation and S1P production were comparable to saline controls in LPS-free 
OVA-treated samples. Of note, other studies have reported pro-inflammatory 
responses following LPS/TLR4 signaling (Dong et al., 2009; Eisenbarth et al., 
2002), perhaps due to differences in experimental procedures, timing of 
exposure and dose effect. Overall, our results suggest that LPS penetration of 
the skin through the compromised barrier may prime initial inflammatory 
responses, independently of Ag, as recently suggested (Yoon et al., 2016), 
6.3 OVA TRIGGERS MC-RELATED PRODUCTION OF PRO-APOPTOTIC 
CERAMIDES AT ATOPIC DERMATITIS ONSET 
Ceramides (CER) are the dominant lipid species within skin and have a 
key role in skin barrier maintenance. Skin of AD patients displays decreased 
levels of very long chain CER. Analysis of CER species, following 7-day OVA 
exposure, highlighted augmentation of total skin CER compared to saline 
controls. CER profiling indicated that the observed increase was specific to CER 
C16 and C24 species. In general, CER are considered pro-apoptotic and further 
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investigation revealed increased detection of cleaved Casp3 in OVA-challenged 
skin. Further skin analysis revealed localized increase of CHOP, which initiates 
the Caspase cascade downstream of ER stress. Surprisingly changes in CER 
composition were not observed in OVA-treated MC-deficient KitWsh/Wsh mice, but 
were restored following MC reconstitution, indicating a potential role for MC in 
CER accumulation. To further investigate this, we activated BMMC in vitro with 
S1P, a likely stimulus of MC as we have shown doubling of skin-associated S1P 
at the inception of AD in this model. Interestingly we detected a significant 
increase in C16 and C24 CER species following a 16-hour activation period. 
Furthermore, mRNA expression of ceramide producing enzymes CerS and 
ceramidase was increased within 3 hours of S1P stimulation.  
Overall, this work features concerted interplay between MC/S1P/CER axis 
and early development of AD. These studies highlight MC and S1P as potential 
prophylactic targets that could interfere with disease onset and progression. 
6.4 DOWN-REGULATION OF MIRNA 34A, 485 AND 486 REGULATES AD 
PATHOGENESIS 
We report, for the first time, evidence for epigenetic regulation of pre-
symptomatic remodeling in AD using an established mouse human AD-like 
model.  We found that the skin exposure to Ag OVA triggered the downregulation 
of a unique miRNA triad whose predicted gene targets included AD-related 
cytokines/chemokines downstream of the MC/S1P signaling pathway. While the 
potential ability of these miRNA to regulate cellular infiltration has yet to be 
established, their down-regulation was accompanied with a significant increase in 
FCεRIα, SphK1 and CCL5 mRNA expression, predicted target genes coding for 
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cellular, enzymatic and molecular elements we already proved important to 
disease manifestation (Chapter 3). 
Sonkoly et al. and Rebane et al. recently conducted miRNA profiling of 
human skin lesions and keratinocytes during chronic AD, compared to healthy 
controls (Rebane et al., 2014; Sonkoly et al., 2010). Importantly, their studies 
also identified down-regulation of miRNA 34a and 486, however without offering 
any mechanistic and/or functional insights. We demonstrate that these miRNA 
are similarly affected in mice and, more importantly, are affected at AD onset as 
well, highlighting their potential as prophylactic targets.
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Figure 6.1 Inflammatory changes occur early after topical application of LPS-containing OVA in an established 
mouse human AD-like model.  Skin shaving and tape-stripping first expose keratinocytes to LPS-containing OVA. LPS 
ligation of TLR4 on keratinocytes (and on MC) may result in S1P secretion that, in turn, can activate MC. MC activation 
leads to substantial local elevation of S1P and T cell-attracting chemokine CCL2, CCL3 and CCL5 release, resulting in 
cellular infiltration of the vascularized hypodermis. Furthermore, skin lipidomics revealed local increase in apoptosis-
promoting ceramide (CER) species, due in part to MC. These pre-symptomatic effector mechanisms were epigenetically 
regulated by the down-regulation of miRNA 34a, 485 and 486a.
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